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1 SUMMARY 
The kidney is especially vulnerable to toxic insult by various drugs and 
xenobiotics because it receives nearly one quarter of the cardiac output, and 
transports, metabolizes and concentrates a variety of potentially toxic substances 
within its parenchyma As a consequence of its primary functions, the kidney is 
especially vulnerable to toxic insults by various drugs or xenobiotics, and thus 
nephrotoxicity is one of the major concerns in safety evaluation. Thus, despite the 
morphological complexity of the kidney, the epithelial cells of proximal tubule 
stand out as one of the most sensitive components in the kidney and are thus 
highly susceptible to damage.  
Traditional markers of kidney toxicity, blood creatinine and urea, have some 
limitations. First, significant changes may not occur until frank renal damage has 
occurred (determined by histopathology assessment and/or functional tests) and 
second they are not region specific. 
As a consequence of the difficulties in assessing renal damage by currently 
available/traditional biomarkers,  there is an ongoing interest in developing new, 
early biomarkers of nephrotoxicity. Integratation of emerging transcription 
profiling technologies into traditional drug safety assessment evaluations offers 
the possibility to take new steps toward understanding mechanism of target organ 
toxicity and elucidating putative new biomarkers of exposure and safety. 
The renal toxicity process is typically initiated by a toxic injury to tubular 
epithelial cells in various nephron segments and this initial injury is often 
followed by cellular proliferation and repair that attempts to restore normal renal 
function. Changes in the expression of mRNA specifically expressed in the 
injured kidney cells are some of the earliest events that accompany the renal 
injury. This is accompanied by changes in the expression of other genes that 
contribute either to cellular repair or recovery of renal function. In many of 
published literature employed microarray technology has been used to identify 
some patterns of gene expression that reflect different types of nephrotoxicity. 
Signature of genes designed to indicate nephrotoxicity obtained need to be 
validated with an independent gene expression detection technology such as 
quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR).  
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The objective of the present work was to evaluate potential molecular markers of 
proximal tubular damage in rat kidney caused by segment-specific toxic agents . 
A molecular biology approach has been applied to evaluate the expression of a 
selected panel of four genes that are involved in different mechanisms of toxicity 
and can reflect different types of nephrotoxicity. The selected genes, Kidney 
injury molecule-1 (Kim-1), Clusterin (Cln), Osteopontin (Spp1), and Regucalcin 
(Rgn) are involved in different pathways, such as tissue damage,  remodeling and 
regeneration, disruption of calcium homeostasis, oxidative stress. 
Gene expression was quantified by Real-Time quantitative Polymerase Chain 
Reaction (qRT-PCR) in kidney samples from male rats treated with HCBD, 
K2Cr2O7, and Cephaloridine, three nephrotoxicants that primarily injure specific 
regions of the proximal tubule via different mechanisms of action.  
Conventional clinical chemistry and histopathological analysis were performed to 
confirm the induction of segment-specific proximal tubule damage caused by 
chemicals. 
Results showed a correlation of gene changes with microscopic modification 
induced by nephrotoxicants. Moreover, the severity in proximal tubular damage 
evidenced in the dose-response experiments with the three compounds, were 
correlated with the magnitude of the transcriptional response. On the contrary, 
traditional clinical markers changes were observed for severe damage only, 
confirming the low sensitivity. Interestingly, even low severity microscopic 
observations were evidenced by gene expression quantification.  
Moreover, since KIM-1 mRNA levels modifications were evidenced also for low 
dose of nephrotoxicants where no morphologic modifications were observed, it is 
likely to represent a potential predictive biomarker of nephrotoxicity.  
In conclusion, this study confirmed that gene expression quantification may be 
used to detect renal tubular damage induced by nephrotoxicants. Genomic 
responses could represent more sensitive tool to monitor renal damage in 
comparison with traditional morphological and biochemical end points.  
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2 INTRODUCTION 
 
2.1 Kidney  
Mammalian kidneys are paired organs present in the retroperitoneum, 
ventrolateral and adjacent to the lumbar vertebral bodies and their corresponding 
transverse process. These complex organs, which function in excretion, 
metabolism, secretion, and regulation, are susceptible to disease insults that affect 
the four major anatomic structures of the kidney: the glomeruli, tubules, 
interstitium, and vasculature.  
 
2.1.1 Kidney structure and function 
Kidneys are organized functionally and anatomically into lobules. Each lobule 
represents collections of nephrons separated by the medullary rays (Fig. 1). Renal 
lobules should not be confused with renal lobes. Each lobe is represented by a 
renal pyramid. Kidneys are covered by a diffuse fibrous capsule.  
 
 
Fig. 1. Schematic diagram of kidney dorsal section (based on Illustrated Veterinary Anatomical 
Nomenclature, Kinderhook,  NY, 1992). 
 
The renal parenchyma is divided into a cortex and medulla. The medulla generally 
can be subdivided into an outer zone, that portion of the medulla close to the 
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cortex, and the inner zone, that portion closer to the pelvis. Papillae are 
surrounded by minor calyces that coalesce to form major calyces, which empty 
into the renal pelvis, where urine collects before entry into the ureters. 
Rat kidney has a basic unipapillary architecture, the simplest type of mammalian 
kidney. In transverse section, the cortex and outer stripe of the outer medulla can 
be differentiated from the inner stripe of the outer medulla and the inner medulla 
with the papilla extending into the renal pelvis (Fig. 2). 
The kidneys receive blood primarily through the renal artery. An interlobar artery 
extends along the boundary of each renal lobe (renal column) and then branches at 
right angles to form an arcuate artery that runs along the corticomedullary 
junction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Nephron topography (from Handbook of Toxicology Pathology, Academic Press, San 
Diego, CA)  
 
 
 
 
Proximal convoluted tubule = 
PCT (S1-S2) 
Pars recta = PR (S3 segment) 
Loop of Henle = HL 
Thick Ascending limb = TAL 
Distal convoluted tubule = DCT 
Collecting duct = CD 
Outer stripe of  
outer medulla 
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2.1.1.1 Microscopic structure and physiology 
The functional unit of the kidney is the nephron which includes the renal 
corpuscle (glomerulus within Bowman’s capsule), and a tubular system that 
includes the proximal tubules, the loop of Henle and the distal convoluted tubule, 
which empties into the collecting tubule (Fig. 3).  
 
 
Fig. 3. Schematic diagram of the nephron (from vzajic.tripod.com/8thchapter.html). 
 
The glomerulus is composed of a capillary network lined by a thin layer of 
endothelial cells, a central region of mesangium, and epithelial cells (podocytes). 
The glomerulus represents the filtering unit for blood through which the plasma 
filtrate is derived in the first part of the uriniferous space. The filtering membrane 
of the glomerulus consists of fenestrated capillary endothelial cells, a glomerular 
basement membrane, and visceral epithelial cells or podocytes. Discrimination in 
glomerular filtration for larger molecules occurs based on molecular size, 
configuration and charge. In addition to the principal glomerular function of 
plasma filtration, glomerular functions also include regulation of blood pressure 
by means of secreting vasopressor agents and/or hormones, regulation of 
peritubular blood flow, regulation of tubular metabolism, and removal of 
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macromolecules from circulation by the glomerular mesangium. Integral to these 
functions is the juxtaglomerular apparatus, which functions in tubuloglomerular 
feedback by autoregulating renal blood flow and glomerular filtration rate.  
The proximal tubule is lined by columnar epithelial cells that have a microvillous 
(brush) border, which greatly increases their absorptive surface. A major function 
of the proximal tubules is to reabsorb sodium, chloride, potassium, albumin, 
glucose, water, and bicarbonate. This is facilitated by luminal brush border, 
basolateral infoldings, magnesium-dependent sodium and potassium pumps, and 
transport proteins. The proximal tubule begins at the urinary pole of the 
glomerulus and consists of an initial convoluted portion, the proximal convoluted 
tubule (PCT), which is a direct continuation of the parietal epithelium of 
Bowman’s capsule and a straight portion, the pars recta, which is located in the 
outer stripe and/or medullary ray. The proximal tubule is divided into three 
segments (S1, S2, and S3) in several animal species, including rat (Fig. 2). The S1 
segment is short, connecting with the glomerular filtration space. Cells of this 
segment have the highest rate of oxidative metabolism in the kidney. The S2 
segment represents the vast majority of the PTC and extends a short distance into 
the pars recta. The vast majority of the pars recta consists of the S3 segment.  
The transition from the proximal tubule to the thin descending limb of the loop of 
Henle is abrupt and marks the boundary between the inner stripes of the outer 
medulla. Four epithelial cell types are described in the thin descending and the 
thin ascending limbs of the loop of Henle. Ultrastructurally, they vary from non-
specialized cells without interdigitation to cells with interdigitation and 
specialization, evidenced by a variation (increase) in the cytoplasmic number of 
mitochondria, and intramembranous particles, and the surface number of 
microvilli. The lenth of Henle’s loop varies, with subcapsular nephrons having a 
very short loop extending only in the outer stripe. Nephrons arising in the 
midcortex have loops extending midway through the inner medulla. 
Juxtamedullary nephrons extend deep into the papilla. The transition from the pars 
recta to the descending loop of Henle results in a reduction in the outside diameter 
with only a slight change in luminal diameter. An osmotic gradient is estebilished 
and maintained by selective permeability in the loop of Henle (countercurrent 
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multipliers) and passive diffusion in the vasa recta (countercurrent exchangers). 
This forms the basis for a countercurrent system in which inflow runs parallel to, 
in intimate proximity with, and opposite to outflow. The ability of the kidneys to 
concentrate urine is dependent on the gradient of increasing interstitial osmolarity 
running from the outer medulla to the tip of the papilla created by countercurrent 
system (Fig. 4). 
 
Fig. 4. Schematic diagram of the counter-current multiplier and exchanger. (From 
openlearn.open.ac.uk/.../2815/formats/print.htm)  
 
The distal nephron is composed of three structurally distinct segments: the thick 
ascending limb of the loop of Henle, in the outer zone of the medulla and in the 
cortex, the macula densa, and the distal convoluted tubule. The macula densa (Fig. 
5) is one of the components of the juxtaglomerular apparatus, with the renin-
producing granular cells of the afferent arteriole, and the extraglomerular 
mesangium.  
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Fig. 5. Schematic diagram of the juxtaglomerular apparatus (from 
kcampbell.bio.umb.edu/.../Session%203.html) 
 
The juxtaglomerular apparatus functions in tubuloglomerular feedback 
autoregulating renal blood flow and glomerular filtration rate by the renin-
angiotensin-aldosterone system (Fig. 6). 
 
 
Fig. 6. Schematic diagram of the renin-angiotensin-aldosterone system  
 
The distal convoluted tubule (DTC) begins at a variable distance beyond the 
macula densa and extends to the connecting tubule that connects the nephron with 
the collecting duct, which pass through the renal cortex and medulla, to empty 
into pelvis of the kidney at the apexes of the medullary pyramids. The epithelium 
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of the DTC is lower than that of the PTC. Although microvilli are present, they 
are not in significant numbers to form a distinctive brush border. DTC cells are 
involved in sodium and vasopressin stimulated water reabsorption. 
2.1.1.2 Renal function 
Renal function can be summarized into five basic components: 
1. formation of urine for the purpose of elimination of metabolic wastes; 
2. acid-base regulation, predominantly through reclamation of bicarbonate from 
the glomerular filtrate; 
3. the conservation of water through reabsorption by the proximal convoluted 
tubules, the countercurrent mechanism of the loop of Henle, antidiuretic 
hormone activity in the distal tubules, and the urea gradient in the medulla. 
The tubular system is capable of absorbing up to 99% of the water in the 
glomerular filtrate; 
4. the maintenance of normal extracellular potassium ion concentration through 
passive reabsorption in the proximal tubules and tubular secretion in the distal 
tubules under the influence of aldosterone; 
5. endocrine function through three hormonal axes: renin-angiotensin, most 
importantly, but also erythropoietin and vitamin D. Erythtopoietin, produced 
in the kidneys in response to reduced oxygen tension, is released into the 
blood and stimulates bone marrow to produce erythrocytes. Vitamin D is 
converted in the kidneys to its most active form (1,25-
dihydroxycholecalciferol [calcitriol]), which facilitates calcium absorption by 
the intestine. 
2.2 Kidney toxicity 
The kidney is especially vulnerable to toxic insult by various drugs and 
xenobiotics because it receives nearly one quarter of the cardiac output, and 
transports, metabolizes and concentrates a variety of potentially toxic substances 
within its parenchyma (Toback et al., 1992; Bennett et al., 1997).  
As a consequence of its primary functions, the kidney is especially vulnerable to 
toxic insults by various drugs or xenobiotics, and thus nephrotoxicity is one of the 
major concerns in safety evaluation. Since 90% of the blood that reaches the 
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kidney flows through the renal cortex, it is not surprising that many xenobiotics 
and their metabolites affects the cells of the proximal tubules after passing the 
glomeruli, and since the proximal tubule reabsorbs 60-80% of solute and water, 
toxicant-induced injury frequently affects the water and solute balance. Thus, 
despite the morphological complexity of the kidney, the renal tubule epithelial 
cells stand out as one of the most sensitive components in the kidney and are thus 
highly susceptible to damage. 
 
2.2.1 Mechanisms of toxicity  
Xenobiotic-associated kidney injury typically depends on selective concentration 
of the toxic moiety at the target cell or subcellular organelle. This concentration is 
favored by normal function of the kidney. The magnitude of blood flow per gram 
of renal parenchyma is higher than for any other tissue. Glomerular filtration with 
tubular reabsorption serves to further concentrate potentially toxic moieties. 
Tubular transport occurs via protein binding with endocytosis, via active or 
passive link with ATP hydrolysis-dependent transport such as the sodium pump, 
or via organic anion or cation transport. Concomitantly, selective membrane 
permeability may serve to maintain critical concentrations of molecules 
concentrated via transport. 
The kidney has the capacity to dissociate protein-bound toxins; such binding 
serves to protect other tissues from the injurious agent. The kidney also has the 
capability to alter the pH of tubular fluid, which can serve to transform solutes to 
a reactive form. Finally, the kidney partecipates in the metabolism of xenobiotics. 
Renal metabolism with derivation of reactive electrophilic intermediates causes 
injury following covalent reaction or peroxidative reaction with the target cell 
mecromolecules.  
 
Classification of nephrotoxins 
Nephrotoxins can be categorized according to intrinsic structural or functional 
characteristics of the xenobiotic (Table 1). 
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Naturally occuring organic toxins Nonsteroidal anti-inflammatories 
Afatoxin Acetaminophen 
Bacterial toxins Ibuprofen 
Furan derivates Indomethacin 
Miscellaneous therapeutics Cancer therapeutics/Immunosuppressors 
Interferon Cisplatin 
Cimetidine Vincristine 
Isoniazid Puromycin 
Iron Nitrosourea 
Zinc Cyclosporin A 
Metals Herbicides 
Aluminum Bipyridium compounds 
Arsenic Insecticides 
Cadmium Chlorinated hydrocarbons 
Mercuric chloride Organophosphorous 
Gold Antibiotics 
Lead Cephaloridine 
Lithium Gentamicin 
Glycols/Alogenated alkenes Tetracycline 
Hexachloro-1,3-butadiene Streptomycin 
 
Table 1 Listing and classification of nephrotoxins according to functional characteristics of the 
inducing agent (Kanwar NM et al., Handbook of Toxicology Pathology, Volume 2, Academic 
Press, 1991) 
 
 
Xenobiotic causing kidney injury can be also classified into one of the following 
five mechanistic categories: (1) directly perturbing cellular or subcellular 
organelle function, (2) causing injury via reactive intermediates or peroxidative 
stress, (3) perturbing levels of cellular, interstitial, or lumen substrate, (4) 
perturbing renal hemodynamics, or (5) eliciting immune-mediated injury. 
 
2.2.2 Proximal tubular toxicity  
Several xenobiotic substances damage renal proximal tubule, the portion of the 
nephron with the greater sensitivity to nephrotoxic effects. Proximal tubular 
toxins frequently affect both convoluted and straight segments. These segments 
may be differentially affected by xenobiotics through the five basic mechanistic 
categories described above.  
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The proximal convoluted tubule (S1 and S2 segments) contains a very active 
endocytosis/lysosomal apparatus, thus representing the site of injury related to 
lysosomal overload, as well as protein-bound toxic moieties.  
The straight portion of the proximal tubule (S3 segment) represents the most 
susceptible site of injury via metabolic activation, transporter-associated 
accumulation, and hypoxia/reperfusion (Khan et al., 2002). 
Among chemicals damaging the proximal tubule are antibacterial drugs such as 
cephaloridine (Silverblatt et al., 1970) and aminoglycosides (Wellwood et al., 
1976), which selectively affect S1-S2 segments, anticancer drugs such as cis-Pt 
(Dobyan et al., 1980), which affects S3 segment, industrial chemicals (metals and 
solvents) such as cadmium (Squibb et al., 1979) and hexavalent chromium (Biber 
et al., 1968; Evan and Dail, 1974), which affects S1-S2 segments, or mercury 
(Eknoyan et al., 1982; Dobyan and Bulger, 1984), hexachlorobuta-1,3-diene or 
HCBD (Ishmael et al., 1982), and palladium (Trevisan et al., 2002), which affect 
S3 segment. 
2.2.3 Histopathology findings  
Renal tubular epithelial cells respond to nephrotoxicants by undergoing 
degeneration, necrosis or apoptosis. Degeneration is the result of a mild, 
potentially reversible injury. Degenerating cells are characterized histologically by 
pale, swollen cytoplasm, containing large, variably sized clear vacuoles (vacuolar 
degeneration). These features are the consequence of the nephrotoxicant-induced 
alteration in the intracellular electrolytes balance, leading to net influx of water, 
which, in turn, caused swelling of the plasma membrane and cytoplasmic 
organelles (mitochondria, smooth and rough endoplasmic reticulum, Golgi 
apparatus, lysosomes). For those cells more severely and irreversibly injured, 
death occurs by two mechanisms, necrosis and, less frequently, apoptosis. 
Necrotic cells are characterized by slightly swollen, brightly eosinophilic 
cytoplasm due to loss of normal basophilia imparted by RNA in the cytoplasm or 
to increased binding of eosin to denaturated intracytoplasmic proteins. Nuclear 
changes include shrinkage, fragmentation and  fading (named pyknosis, 
karyorrhexi and  karyolysis, respectively) or, with the passage of time, nuclei 
totally disappear. Apoptotic cells appear as round, brightly eosinophilic structures, 
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with condensed chromatin, individualized from the adjacent epithelial cells. 
Necrotic and apoptotic cells exfoliate into the lumen, leaving an intact basement 
membrane. Evidences of tubular epithelium regeneration, following 
nephrotoxicants induced injury, are represented by flattened cells with deeply 
basophilic cytoplasm, plump vesicular nuclei and prominent nucleoli and mitotic 
figures. 
 
 
2.2.4 Clinical biomarkers 
Traditional markers of kidney toxicity are blood urea nitrogen (BUN) and serum 
creatinine measurements. Urea and creatinine are nitrogenous end products of 
metabolism. Urea is the primary metabolite derived from dietary protein and 
tissue protein turnover. Creatinine is the product of muscle creatine catabolism. 
Both are relatively small molecules (60 and 113 daltons, respectively) that 
distribute throughout total body water. In Europe, the whole urea molecule is 
assayed, whereas in the United States only the nitrogen component of urea (the 
blood or serum urea nitrogen, i.e., BUN or SUN) is measured. The BUN, then, is 
roughly one-half of the blood urea. 
The BUN and creatinine are screening tests of renal function. Because they are 
handled primarily by glomerular filtration with little or no renal regulation or 
adaptation in the course of declining renal function, they essentially reflect the 
glomerular filtration rate (GFR). The GFR is clinically important because it is a 
measurement of renal function. Unfortunately, their relation to GRF is not a 
straight line but rather a parabolic curve. Their values remain within the normal 
range until more than 50% of renal function is lost. 
Thus, these traditional markers of kidney toxicity have two limitations (Duarte 
and Preuss, 1993). First, significant changes may not occur until frank renal 
damage has occurred (determined by histopathology assessment and/or functional 
tests) and second they are not region specific. 
Also urinary enzymes are used to determine damage along the nephron and to 
define subcellular involvement (Price et al., 1982). The lysosomal enzyme N-
acetylglucosaminidase (NAG) and the brush border enzyme γ-
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glutamyltranspeptidase (GGT) have also been used to assess renal toxicity (Gibey 
et al., 1981; Scherberich and Mondorf, 1983). When tubules are damaged, NAG 
and GGT are excreted into the lumen of the tubules and can be detected in the 
urine. However, a limiting factor in the use of these enzymes, particularly NAG, 
is the considerable intra and inter-individual variation in urinary enzyme activity 
(Naidu and Lee, 1994). Consequently, 24-hour urine collection must be obtained 
to allow for diurnal variation of excretion and urine volume.  
Recently, urinary levels of specific enzymes have been proposed as 
topographically specific markers of renal damage (Kilty et al. 1998). The 
proximal tubule is the portion of the nephron with greater sensitivity to 
nephrotoxic effects of chemicals, and it is the site of several metabolic activities. 
Enzyme distribution along the proximal tubule segments is well defined for a 
number of these (Guder and Ross, 1984). Particularly, glutamine synthetase (GS) 
enzyme which is localized only in the early and late portion of the S3 segment 
(Burch et al., 1978). GS is a mitochondrial enzyme present in a variety of tissues 
including kidney (Iqbal and Ottaway, 1970). According to the S3 segment-
specific localization, GS activity in urine is able to identify a damage of this 
segment. At the moment, GS is the only known enzyme with an exclusively 
segmentary localization; therefore, this enzyme may identify only whether a 
xenobiotic substance affects S3 segment by increase of excretion (Trevisan et al., 
1999).  
 
2.2.5 Genomic approach to nephrotoxicity  
As a consequence of the difficulties in assessing renal damage by currently 
available/traditional biomarkers,  there is an ongoing interest in developing new, 
early biomarkers of nephrotoxicity (Duan et al. 1999;Taylor et al., 1997). 
An emerging approach to achieve this objective is the use of genomic 
technologies that are impacting in many areas of drug-discovery and development 
(Afshari et al., 1999).  
Integratation of emerging transcription profiling technologies into traditional drug 
safety assessment evaluations offers the possibility to take new steps toward 
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understanding mechanism of target organ toxicity and elucidating putative new 
biomarkers of exposure and safety. 
The renal toxicity process is typically initiated by a toxic injury to tubular 
epithelial cells in various nephron segments. The initial injury is often followed 
by cellular proliferation and repair that attempts to restore normal renal function 
(Toback et al., 1992). Changes in the expression of mRNA specifically expressed 
in the injured kidney cells are some of the earliest events that accompany the renal 
injury. This is accompanied by changes in the expression of other genes that 
contribute either to cellular repair or recovery of renal function. 
Recent application of microarray-based gene profiling has provided a first insight 
into toxicity-related gene expression changes in the kidney (Amin et al., 2004; 
Thukral et al., 2005). In these works, through comparison of the expression 
profiles derived from kidneys exposed to different known nephrotoxicants 
(associated with varying types and severity of toxicity), some patterns of gene 
expression that reflect different types of nephrotoxicity have been identified. 
The development of toxicity profiles and specific gene expression signatures 
requires the use of standardized conditions and the testing of a number of drugs of 
distinct classes and mechanisms, and therefore they are usually developed on one 
platform technology. Analytical validation of the veracity of gene changes within 
a signature is usually performed with an independent gene expression detection 
technology such as quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR). 
 
2.3 Objective of the thesis 
The objective of the present work was to evaluate potential molecular markers of 
proximal tubular damage in rat kidney caused by segment-specific toxic agents . 
A molecular biology approach has been applied to evaluate the expression of a 
selected panel of four genes that are involved in different mechanisms of toxicity 
and can reflect different types of nephrotoxicity. 
Conventional clinical chemistry and histopathological analysis were performed to 
confirm the induction of segment-specific proximal tubule damage caused by 
chemicals. 
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In details, the work was structured in the following experimental steps (Scheme 
1): 
? Treatment of male rats with three different nephrotoxicants selective for the 
proximal tubule segments; 
? Kidney processing through gene expression quantification by quantitative 
real-time polymerase chain reaction (qRT-PCR); 
? Kidney histopathology evaluation; 
? Blood clinical chemistry markers measurement. 
? Gene expression, histopathology and blood biochemical markers data 
integration. 
In the first part of the work, as a low-scale validation of the selected genes panel, 
two xenobiotic chemicals (Potassium dicromate (K2Cr2O7) and Hexachlorobuta-
1,3-diene (HCBD)) were used due to their characteristic to selectively affect the 
different segments of the proximal tubule.  
A single toxic dose for each chemicals was used to treat rats with different ages to 
monitor the proximal tubule damage and to identify the most susceptible stage 
(ageing study). Moreover, another study was set up using three different doses of 
the two chemicals in rats with the same age (dose-response study). 
In the second part of the work, a drug known to induce a proximal tubule 
segment-specific injury, cephaloridine,  was tested at different doses in rats (dose-
response study). Results were compared with those obtained in the low-scale 
validation phase. 
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Scheme 1. Flow chart of experimental phases used in the work of thesis. 
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2.3.1 Genes evaluated  
Kidney injury molecule-1 (Kim-1) is a type 1 transmembrane protein that is not 
detectable in healthy kidney tissue. Transcript levels for the gene that encodes 
Kim-1 are strongly upregulated in dedifferentiated proximal tubule epithelial cells 
in kidney after ischemic or toxic injury.  
Renal epithelial cell injury is a feature of many acute and chronic renal diseases. 
Morphologic characteristics of injury to the proximal tubule epithelial cell include 
loss of proximal tubular brush border, loss of cellular polarity, dedifferentiation, 
and apoptosis. With advanced injury, viable and necrotic tubular epithelial cells 
detach from the basement membrane and contribute to intraluminal obstruction. 
Surviving dedifferentiated cells spread over the denuded basement membrane, 
undergo mitogenesis, and ultimately redifferentiate and reestablish normal 
epithelial polarity resulting in a normal functional epithelium (Scheridan et al., 
2000; Thadhani et al., 1996). Although these processes are well described at the 
histopathological level, very little is known about the molecular factors that 
regulate these events. One of the genes identified from postischemic rat kidney by 
representational difference analysis (Hubank et al., 1994) was designated as KIM-
1 (Ichimura et al., 1998). This gene encodes a type I cell membrane glycoprotein 
containing, in its extracellular portion, a six-cysteine immunoglobulin-like domain 
and a mucin domain. Immunoglobulin-like domains have been widely implicated 
in mediating protein-protein interaction (Barclay et al., 1999) in particular at the 
cell surface where they are responsible for cell-cell and cell-extracellular matrix 
interactions. The mucin domain could play a dual role of configuration and 
protection (Jentoft et al., 1990) as well as being involved in cell adhesion. The 
cytoplasmic domain of KIM-1 is relatively short and possesses a potential 
phosphorylation site, indicating that KIM-1 may be a signaling molecule.  
Rat KIM-1 mRNA and protein levels are dramatically up-regulated in the 
postischemic kidney. In situ hybridization and immunohistochemistry revealed 
that KIM-1 is expressed in dedifferentiated proximal tubular epithelial cells in 
damaged regions, especially in the S3 segment of the proximal tubule in the outer 
stripe of the outer medulla, a region that is highly susceptible to injury as a result 
of ischemia or toxins (Ichimura et al., 1998). Because KIM-1 colocalizes with 
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markers of proliferation, KIM-1 has been proposed to play a  role in the 
regeneration process.  
 
Clusterin (Cln) is a heterodimeric glycoprotein and it is widely and prominently 
induced in injured tissue, particularly when such injury involves the kidney and 
the brain. While the function of clusterin in injury remain uncertain, a number of 
studies point to cytoprotective actions of clusterin induced in such settings. 
Clusterin induces aggregation of some but not all cells in vitro and also is a potent 
cell adhesion molecule (Silkensen et al., 1999). Prolonged incubation of cells with 
clusterin results in the formation of junctional contacts between cells and 
expression of cell adhesion molecules. Clusterin may also be involved in more 
complex cell interactions.  
Abnormalities in cell interactions occur following renal injury leading to cell 
rounding, retraction and detachment; decreased binding of cells to matrix 
components is also recognized as well as aberrant cell-cell attachments (Silkensen 
et al., 1995). Loss of intercellular contact may also induce apoptosis. The loss of 
cell-cell and cell-substratum interactions incurs detachment of tubular epithelial 
cells and in turn, denudation of the epithelium and tubular back leak of filtrate. 
Thus, even mild injury can lead to profound nephron dysfunction mediated in part 
through alterations in cell attachment. Loss of normal cell interactions from their 
usual cellular contacts and substratum lead to variable effects on cellular viability. 
In the setting of renal injury, promoting cell-cell contacts may enhance cell 
survival by allowing the exchange of critical nutrients or other factors between 
cells, or by providing the correct intracellular signals to prevent apoptosis. 
Promoting cell-substratum contacts would prevent sloughing of cells. In addition, 
maintenance of cell proximity would allow the normal junctional contacts to 
become re-established once the phase of injury subsides and the processes of 
repair and regeneration are initiated. 
The prominent induction of clusterin in tubules following injury coupled with the 
capacity of this protein to promote cell interactions led to hypothesize that the 
induction of clusterin in states of injury provides an adaptive response that 
attenuates injury that otherwise occurs.  
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Immunohistochemistry and in situ hybridization demonstrated clusterin primarly 
in the inner stripe of the outer medulla (Silkensen et al., 1996). 
 
Regucalcin (Rgn) is a Ca2+-binding protein and it  plays a pivotal role in 
maintaining intracellular calcium homeostasis by activating Ca2+ pump enzymes 
in the plasma membrane (basolateral membrane), microsomes (endoplasmic 
reticulum) and mitochondria of many cell types. Regucalcin has a suppressive 
effect on calcium signaling from the cytoplasm to the nucleus in the proliferative 
cells. Also, regucalcin has been demonstrated to transport to nucleus, and it can 
inhibit nuclear protein kinase, protein phosphatase, and deoxyribonucleic acid 
(DNA) and ribonucleic acid (RNA) synthesis. Regucalcin can control 
enhancement of cell proliferation due to hormonal stimulation (Yamaguchi et al., 
2000).  
The kidney plays a physiologic role in the regulation of calcium homeostasis in 
blood by reabsorption of urinary calcium.It has been demonstrated that regucalcin 
mRNA is expressed in the kidney cortex but not the medulla of rats, and that the 
expression may be mediated through Ca2+/calmodulin action induced by calcium 
administration (Yamaguchi et al., 1995). This suggests a role for regucalcin in 
calcium metabolism of kidney cells. Presumably, regucalcin is responsible for 
ATP-dependent transcellular Ca2+ transport, and it participates in the promotion of 
Ca2+  reabsorption in the nephron tubulo of kidney cortex. Kidney regucalcin may 
play a physiological role in the regulation of calcium metabolism in blood through 
reabsorption of urinary calcium.  
 
Osteopontin (OPN) is a phosphorylated glycoprotein that has many functions in 
cell-cell binding and cell-matrix binding in various organs. Osteopontin is 
synthesized at the highest levels in bone and epithelial tissues and is considered to 
play a role in bone remodelling. OPN is present in normal kidneys, has up-
regulated expression and many potential roles in abnormal kidneys. 
In the normal kidney, OPN shows scattered localization in distal convoluted 
tubules, thick ascending limbs, collecting ducts, and especially in aged rat 
Bowmann's capsule epithelial cells (Lopez et al., 1993). After renal damage, OPN 
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expression may be significantly up-regulated in all tubule segments and 
glomeruli. 
Osteopontin is associated with a number of functions involving regulation of 
osteoclast function during bone formation, renal stone formation, tumorigenesis 
and transformation, and accumulation of macrophages (Denhardt et al., 1993). In 
addition, it has immune functions, inhibits induction of inducible nitric oxide 
synthase (iNOS), and protects cells from apoptosis as a survival factor. Recently, 
it has been demonstrated that OPN is associated with cell proliferation and 
regeneration in the recovery process after renal injury (Xie et al., 2001). 
OPN has some protective actions in renal injury, such as increasing tolerance to 
acute ischemia, inhibiting inducible nitric oxide synthase and suppressing nitric 
oxide synthesis, reducing cell peroxide levels and promoting the survival of cells 
exposed to hypoxia, decreasing cell apoptosis and participating in the regeneration 
of cells. In addition, OPN is associated with renal stones, but whether it acts as a 
promoter or inhibitor of stone formation is controversial. 
The expression of OPN is up-regulated in the injury and recovery processes of a 
lot of tissues and cells, including inflammation, fibrosis, mineralization and 
regeneration of kidneys, bone heart, vessels and cultured cells. Its expression is 
regulated by many factors including hormones, growth factors, cytokines, vitamin 
D3, calcium, phosphate and drugs. 
 
 
2.3.2 Nephrotoxicants used  
Hexachlorobuta-1,3-diene (HCBD), a halogenated alkene, is a selective 
nephrotoxin and a nephrocarcinogen in rats, damaging selectively the pars recta of 
the proximal tubules (Boroushaki et al., 2003). Its organ-specific toxicity is based 
upon a multistep bioactivation mechanism involving hepatic and renal enzymes 
(Scheme 2) (Birner et al., 1997). Coniugation in Phase II metabolism with 
glutathione (GSH), typically decreases the reactivity of the metabolic 
intermediate, correspondingly reducing toxicity potential. There is now evidence 
however, that stable GSH conjugates , which are degraded to cysteine conjugates, 
may be sebsequently bioactivated to a toxic metabolite by a renal cysteine 
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conjugate ß-lyase (ß-lyase pathway). ß-lyase cleaves S-cysteine conjugates to 
putative reactive thiols. ß-lyase enzyme activity is localized mainly in the pars 
recta. For this reason , glutathione conjugation appears to be the only 
bioactivation pathway leading to reactive intermediates. These thiols are 
accumulated in the kidney by the organic anion transport system and is thought to 
be responsible for nephrotoxic effects observed in rats.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. Bioactivation of Hexachlorobutadiene by Glutathione Conjugation (from Birner et al., 
1997) 
 
Potassium dichromate (K2Cr2O7) is a chemical compound widely used in 
industry. The oxidation state and solubility of chromium (Cr) compounds 
determine their toxicity. In contrast to Cr3+, which is a naturally occurring form 
and an essential trace element for humans and others mammals, Cr6+ compounds 
are highly toxic (Wang et al., 2006). K2Cr2O7 is a hexavalent form of Cr and has 
been demonstrated to induce oxidative stress and carcinogenic in nature (Stohs 
and Bagchi, 1995, and Bagchi et al., 2002). The kidney is the principal route of Cr 
excretion and it has been reported that acute exposure induces an increase in Cr 
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kidney content on K2Cr2O7-treated rats (Pedraza-Chaverri et al., 2005). Exposition 
to Cr6+ produced anatomical lesions at the level of the proximal tubular cells. the 
first two proximal tubule segments, S1 and S2, are the primary cellular targets for 
Cr6+ toxicity. Interestingly, evidences suggest that reactive oxygen species (ROS) 
are involved in Cr6+-induced cell injury (Stohs and Bagchi, 1995; Bagchi et al., 
2002; and Travacio et al., 2001). Cr reduction intermediates, Cr5+ and Cr6+ , may 
be toxic as they involve ROS production (Stohs et al., 2000; Shi and Dalal, 1994) 
which may be generated during physiological conditions. In vitro, chromate 
reduction via hydrogen peroxide (H2O2) has been shown to produce hydroxyl 
radical (OH ) via a Fenton-like reaction (O´Brien and Kortenkamp, 1994; Liu et 
al., 1997 and Tsou et al., 1996). In vivo experiments have been shown that 
K2Cr2O7 exposition induces oxidative and nitrosative stress measured as protein 
carbonyl content and 3-nitrotyrosine (3-NT) immunostaining (Pedraza-Chaverri et 
al., 2005). The role of oxidative stress in the renal damage induced by K2Cr2O7 
has been supported by the fact that some antioxidants such as α-tocopherol, 
ascorbic acid, and glutathione (Appenroth and Winnefeld, 1998, Arreola-
Mendoza et al., 2006), and the previous induction of heme oxygenase-1 (Barrera 
et al., 2003a and Barrera et al., 2003b) are able to ameliorate K2Cr2O7-induced 
nephrotoxicity and oxidative damage. 
 
Cephalosporins and other ß-lactam antibiotics cause proximal tubular necrosis in 
human and laboratory animals. Selective toxicity to the proximal tubule occurs 
because of high intracellular concentration achieved by active transport by the 
organic anion transporter. The pars recta represents the segment of nephron with 
greatest injury from cephalosporins. 
As a model cephalosporin, cephaloridine is metabolized in the proximal tubular 
cell and, at sufficiently high concentrations, induces lipid peroxidation-type injury 
to membranes. Evidence for oxidative stress as a mechanism of injury includes (1) 
inhibition of injury by superoxide dismutase, by catalase, by the hydroxyl radical 
scavanger mannitol and by the singlet oxygen scavenger histidine; (2) increase in 
malondialdehyde production in vitro; (3) superoxide anion generation in vitro; (4) 
gluthatione depletion of renal cortex from treated animals; and, (5) potentiation of 
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injury by pretreatment with antioxidant-deficient diets (vitamin E and selenium). 
The importance of metabolism and the generation of reactive intermediates are 
indicated by the demonstration of covalent binding of the renal cortex 
homogenate microsomal fraction by cephalosporins in a quantity proportional to 
their toxic potential. 
 
 
2.3.3 Polymerase Chain Reaction (PCR) and Reverse Transcription 
Polymerase Chain Reaction (RT-PCR) 
The advent of Polymerase Chain Reaction (PCR) by Kary B. Mullis in the mid-
1980s revolutionized molecular biology as we know it. PCR is a fairly standard 
procedure now, and its use is extremely wide-ranging. At its most basic 
application, PCR can amplify a small amount of template DNA (or RNA) into 
large quantities in a few hours. Typical reasons for amplifying particular gene 
sequences are to determine the presence or absence of the sequence, for expample 
DNA of infectious agents, such as mycobacteria (Perosio and Frank, 1993) or 
chromosome translocation (Lee et al., 1987), to determine whether a mutational 
hotspot contains a disease-related mutation or to study clonality of rearranged 
antigen receptor genes in lymphocyte populations (Diss and Pan, 1997). 
PCR reaction is performed by mixing the DNA with oligonucleotide primers, 
complementary to a defined sequence on each of the two strands of the DNA, on 
either side of the DNA (forward and reverse), Taq polymerase (of the species 
Thermus aquaticus, a thermophile whose polymerase is able to withstand 
extremely high temperatures), free nucleotide triphosphates (dNTPs for DNA, 
NTPs for RNA), and appropriate buffer solution. The temperature is then 
alternated between hot and cold to denature and reanneal the DNA, with the 
polymerase adding new complementary strands each time.  
In details, the reaction is first heated to 95oC to melt (denature) the double strand 
DNA into separate starnds. The reaction is then cooled to ~50oC, at which 
temperature the primers will find base-complementary regions in the single strand 
DNA, to which they will stick (anneal). The reaction is finally heated to 72oC, at 
which temperature the Taq enzyme replicates the primed single strand DNA 
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(extension). At the end of one cycle, the region between the two primers has been 
copied once, producing two copies of the original gene region (Fig. 7).   
 
 
 
 Fig.7. Stepwise  representation of PCR  (from  pathmicro.med.sc.edu/pcr/realtime-home.htm) 
 
Because a heat-resistant polymerase is used, the reaction can be repeated 
continuously without addition of more enzyme. Each cycle doubles the copy 
number of the amplified gene: ten cycles produces 2  4   8   16   32   
64   128   256   512  1,024 (210) copies. Thus, 30 cycles yields a (210x3) 
= 109-fold amplification. This produces a sufficient quantity of the gene region of 
interest for direct analysis, for example by DNA sequencing. After several (often 
about 40) rounds of amplification, the PCR product is analyzed by agarose or 
polyacriylamide gel electrophoresis followed by ethidium bromide staining and 
viewing under UV illumination. The choise depends on the product size and 
resolution required. For larger products (300bp and larger) agarose gels are more 
convenient and use less toxic reagents. If smaller fragments must be accurately 
sized, then polyacrylamide gels are required 
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This method of analysis is at best semi-quantitative and, in many cases, the 
amount of product is not related to the amount of input DNA making this type of 
PCR a qualitative tool for detecting the presence or absence of a particular DNA.  
In order to measure messenger RNA (mRNA), the method was extended using 
reverse transcriptase enzyme to convert mRNA into complementary DNA 
(cDNA) which was then amplified by PCR and, again analyzed by gel 
electrophoresis. In many cases this method has been used to measure the levels of 
a particular mRNA under different conditions but the method is actually even less 
quantitative than PCR of DNA because of the extra reverse transcriptase step.  
RT-PCR is important because it permits analysis of mRNA and therefore the 
study of gene transcription and easier analysis of multiple exons.  
 
2.3.4 Real Time Polymerase Chain Reaction and TaqMan 
Technology 
Fairly recently, a new method of PCR quantification has been invented. This is 
called “real-time PCR” because it allows to actually view the increase in the 
amount of DNA as it is amplified.  
The real-time PCR system is based on the detection and quantitation of a 
fluorescent reporter (Lee et al., 1993; Livak et al., 1995). This signal increases in 
direct proportion to the amount of PCR product in a reaction. By recording the 
amount of fluorescence emission at each cycle, it is possible to monitor the PCR 
reaction during exponential phase where the first significant increase in the 
amount of PCR product correlates to the initial amount of target template.  
The generation of PCR products can be monitored during the reaction process 
using fluorescently labelled probes (Lehmann and Kreipe, 2001). 
There are three main fluorescence-monitoring systems for DNA amplification 
(Wittwer et al., 1997a): hydrolysis probes; hybridizing probes; and DNA-binding 
agents. DNA-binding agents, such as SYBR Green are fluorogenic dyes that 
exhibit little fluorescence when in solution, but emit a strong fluorescent signal 
upon binding to double-stranded DNA. Hydrolysis probes include TaqMan probes 
(Heid et al., 1996), molecular beacons (Vet & Marras, 2005) and scorpions (Terry 
et al., 2002). They use the fluorogenic 5' exonuclease activity of Taq polymerase 
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to measure the amount of target sequences in cDNA samples (Svanvik et al., 2000 
for light-up probes). The TaqMan probe was used in this work to measure 
expression levels of genes of interest. 
 
2.3.4.1 TaqMan probe: structure and function 
The TaqMan® probe is a oligonucleotide longer than primers that contains two 
types of fluorophores, which are the fluorescent parts of reporter proteins (Green 
Fluorescent Protein (GFP) has an often-used fluorophore) (Fig. 8).  
While the probe is attached or unattached to the template DNA and before the 
polymerase acts, the quencher (Q) fluorophore (usually a long-wavelength colored 
dye, such as red) reduces the fluorescence from the reporter (R) fluorophore 
(usually a short-wavelength colored dye, such as green). It does this by the use of 
Fluorescence (or Förster) Resonance Energy Transfer (FRET), which is the 
inhibition of one dye caused by another without emission of a proton. The reporter 
dye is found on the 5’ end of the probe and the quencher at the 3’ end. More used 
dyes are TAMRA (6-carboxytetramethylrhodamine) as reporter and FAM (6-
carboxyfluorescein), or TET (tetrachloro-6-carboxyfluorescein), or JOE (2,7-
dimethoxy-4,5-dichloro-6- carboxyfluorescein), or HEX (hexachloro-6- 
carboxyfluorescein) as quencher.   
Once the TaqMan® probe has bound to its specific piece of the template DNA 
after denaturation (high temperature) and the reaction cools, the primers anneal to 
the DNA. Taq polymerase then adds nucleotides and removes the Taqman® probe 
from the template DNA. This separates the quencher from the reporter, and allows 
the reporter to give off its emit its energy (no more FRET). This is then quantified 
using a computer. The more times the denaturing and annealing takes place, the 
more opportunities there are for the Taqman® probe to bind and, in turn, the more 
emitted light is detected. This process occurs in every cycle and does not interfere 
with the exponential accumulation of PCR product.  
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Figure 8. Three step view of the TaqMan® probe working: before the probe is met with the Taq 
polymerase, energy is transferred from a short-wavelength fluorophore (green) to a long-
wavelength fluorophore (red). When the polymerase adds nucleotides to the template strand, it 
releases the short-wavelength fluorophore, making it detectable and the long-wavelength 
undetectable (from http://www.probes.com/handbook/boxes/0422.html) 
  
 
The advantage of fluorogenic probes over DNA binding dyes is that specific 
hybridization between probe and target is required to generate fluorescent signal. 
Thus, with fluorogenic probes, non-specific amplification due to mis-priming or 
primer-dimer artifact does not generate signal. Another advantage of fluorogenic 
probes is that they can be labeled with different, distinguishable reporter dyes. By 
using probes labeled with different reporters, amplification of two distinct 
sequences can be detected in a single PCR reaction. The disadvantage of 
fluorogenic probes is that different probes must be synthesized to detect different 
sequences. 
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There are numerous applications for real-time polymerase chain reaction. It is 
commonly used for both diagnostic and research applications. 
Diagnostically real-time PCR is applied to rapidly detect the presence of genes 
involved in infectious diseases, cancer and genetic abnormalities. In the research 
setting, real-time PCR is mainly used to provide highly sensitive quantitative 
measurements of gene transcription. 
The technology may be used in determining how the genetic expression of a 
particular gene changes over time, such as in the response of tissue and cell 
cultures to an administration of a pharmacological agent, progression of cell 
differentiation, or in response to changes in environmental conditions. 
Also, the technique is used in Environmental Microbiology, for example to 
quantify resistance genes in water samples. 
 
2.3.4.2 Interpretation of gene expression results 
The light emitted from the dye (reporter) in the excited state is received by a 
computer and shown on a graph display, such as this, showing PCR cycles on the 
X-axis and a logarithmic indication of intensity on the Y-axis.  
Using any of the developed chemistries (hydrolysis, hybridizing probes and DNA-
binding) the increase in fluorescence emission can be read by a sequence detector 
in “real Time”, during the course of reaction, and is direct consequence of target 
amplification during PCR. A computer software program calculates a ∆Rn using 
the equation:  
∆Rn= Rn+ - Rn- 
where Rn+   is the fluorescence emission of the product at each time point and Rn- 
is the fluorescence emission of the baseline. Thus, this value expresses the probe 
degradation during the PCR process. The computer software constructs 
amplification plots using the fluorescence emission data that are collected during 
the PCR amplification. The ∆Rn values are plotted versus the cycle number. 
During the early cycles of the PCR amplification, the ∆Rn values do not exceed 
the baseline. An arbitrary threshold is chosen, based on the variability of the 
baseline, usually determined as 10 times the standard deviation of the baseline, set 
from cycles 3 to 15. Threshold cycle (Ct) values are then calculated by 
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determining the point at which the fluorescence exceeds this chosen threshold 
limit. Ct is reported as the cycle number at this point. Therefore, Ct values 
decrease linearly with increasing input target quantity. This can be used as a 
quantitative measurement of the input target (Fig. 9). 
 
Fig.9. Example of an amplification plot. 
 
The high specificity of this method is due to a complementary between the set of 
primers, the internal probe, and the target. Indeed, a fluorescence signal will be 
generated only if the probe is annealed to the target sequence during PCR 
amplification.                                             
2.3.4.3 Quantification approaches 
Generally qRT-PCR assays use one of two standard procedures: absolute or 
relative quantification. Absolute quantification determines the input copy number 
of the transcript of interest, usually by relating the PCR signal to a standard curve. 
Relative quantification describes the change in expression of the target gene 
relative to a control gene (endogenous control or housekeeping gene) or to some 
reference group such as an untreated control or a sample at time zero in a time-
course study (calibrator). Either procedure can be applied for gene expression 
studies that require knowledge of how specific transcript abundance varies within 
a sample set.  
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Thus, two strategies are commonly employed to quantify the results obtained by 
real-time RT-PCR: the standard curve method for absolute quantitation and the 
comparative threshold method for relative quantitation. 
 
 
Endogenous control genes 
Endogenous control, or housekeeping, targets are typically constitutive RNA or 
DNA sequences that are present at a statistically consistent level in all 
experimental samples. By using the endogenous control as an active reference, the 
data from tha amplification of a mRNA target can be normalized for differences in 
the amount of total RNA adedd to each reaction. These reference genes should be 
consistently expressed across the samples being surveyed (e.g. developmental 
series, tissue set, experimental regime).  
Housekeeping genes such as 18S rRNA (ribosomal RNA), β-actin, and GAPDH 
(glyceraldehydes-3-phosphate-dehydrogenase) are commonly used as reference 
genes in qRT-PCR experiments (Bustin et al., 2000 and Olsvik et al., 2005).  
β-actin  mRNA is expressed at moderately abundant levels in most cell types and 
encodes a ubiquitous cytoskeleton protein. GAPDH is ubiquitously expressed, 
moderately abundant message. It is frequently used as an endogenous control for 
quantitative RT-PCR analysis because, in some experimental systems, its 
expression is constant at different times and after experimental manipulation 
(Edwards et al., 1985). However, there is overwhelming evidence suggesting that 
its use as an internal standard is unappropriate (Thellin et al., 1999).  
rRNAs, which constitute 85-90% of total cellular RNA, are useful internal 
controls, as the various rRNA transcripts are generated by a distinct polymerase 
(Paule et al., 2000) and their levels are less likely to vary under conditions that 
affect the expression of mRNAs (Barbu et al., 1989).  
However, many recent studies have shown that expression levels of housekeeping 
genes can vary considerably within a sample set, making them unsuitable for use 
as reference genes for data normalization in qRT-PCR (Dhar et al., 2002; 
Tricarico et al., 2002; Vandesompele et al., 2002; Perez-Novo et al., 2005; and de 
la Vega, 2006).  
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Selection of suitable reference genes is not a simple process. It is desirable to 
validate the chosen normalizer for the target cell or tissue. It should be expressed 
at a constant level at different time points by the same individual and also by 
different individuals at the target cell or tissue (Dheda, 2004). For this reason, 
reference genes for can be reliably selected from microarray expression data 
(Woods et al., 2004) or from high-throughput qRT-PCR assays (ABI TaqMan Rat 
Endogenous Control Panel) which allow rapid screening of a large number of 
housekeeping genes evaluate the expression of select genes.  
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3 MATERIALS AND METHODS 
 
3.1 Test Articles  
Hexachloro-1:3-butadiene (HCBD, purity >97%), potassium dichromate 
(K2Cr2O7), and Cephaloridine hydrate were supplied by Sigma Chemical Co. (St. 
Louis, Mo., USA).  
 
3.2 Animals and treatment 
Investigations were performed on different aged Albino male Wistar rats (C. 
River), kept under standardized conditions, fed with standard diet (Nuova 
Zoofarm, Italy) and drink ad libitum.  
HCBD was dissolved in corn oil, K2Cr2O7 and Cephaloridine were dissolve in 
sterile saline. Doses were selected on the basis of literature information (Trevisan 
et al., 1999; Kurota and Yamaguchi, 1995). Details on animals and treatments are 
reported in Tables 2, 3 and 4. 
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Group Animals/group Treatment Test Compound 
Dose
Somministration Animal age
number Vehicle/Test 
Compound
(mg/kg body wt)
1 4 Corn Oil 0 i.p. 6 weeks
2 4 Sterile Saline 0 s.c. 6 weeks
3 4 HCBD (in Corn oil) 100 i.p. 6 weeks
4 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c. 6 weeks
5 4 Corn Oil 0 i.p. 14 weeks
6 4 Sterile Saline 0 s.c. 14 weeks
7 4 HCBD (in Corn oil) 100 i.p. 14 weeks
8 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c.
14 weeks
9 4 Corn Oil 0 i.p. 26 weeks
10 4 Sterile Saline 0 s.c. 26 weeks
11 4 HCBD (in Corn oil) 100 i.p. 26 weeks
12 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c. 26 weeks
13 4 Corn Oil 0 i.p. 38 weeks
14 4 Sterile Saline 0 s.c. 38 weeks
15 4 HCBD (in Corn oil) 100 i.p. 38 weeks
16 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c. 38 weeks
17 4 Corn Oil 0 i.p. 48 weeks
18 4 Sterile Saline 0 s.c. 48 weeks
19 4 HCBD (in Corn oil) 100 i.p. 48 weeks
20 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c. 48 weeks
 A
ge
in
g 
St
ud
y
3 experiment
4 experiment
5 experiment
1 experiment
2 experiment
 
 
Table 2: Group number, animals/group, treatment, doses, somministration route and animal age for 
ageing study with HCBD and K2Cr2O7 (Phase I). 
 
 
 
Group Animals/group Treatment Test Compound 
Dose
Somministration Animal age
number Vehicle/Test 
Compound
(mg/kg body wt)
21 4 Corn Oil 0 i.p. 8 weeks
22 4 HCBD (in Corn oil) 100 i.p. 8 weeks
23 4 HCBD (in Corn oil) 50 i.p. 8 weeks
24 4 HCBD (in Corn oil) 25 i.p. 8 weeks
25 4 Sterile Saline 0 s.c. 8 weeks
26 4
K2Cr2O7 (in Sterile 
Saline) 25 s.c. 8 weeks
27 4
K2Cr2O7 (in Sterile 
Saline) 12.5 s.c. 8 weeks
28 4
K2Cr2O7 (in Sterile 
Saline) 8 s.c. 8 weeks D
os
e-
R
es
po
ns
e 
St
ud
y 6 experiment
7 experiment
 
 
 
Table 3: Group number, animals/group, treatment, doses, somministration route and animal age for 
dose range studies with HCBD and K2Cr2O7 (Phase I). 
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Group Animals/group Treatment Test Compound 
Dose
Somministration Animal age
number Vehicle/Test 
Compound
(mg/kg body wt)
29 4 Sterile Saline 0 i.p. 8 weeks
30 4
Cephaloridine (in 
Sterile Saline) 100 i.p. 8 weeks
31 4
Cephaloridine (in 
Sterile Saline) 50 i.p. 8 weeks
32 4
Cephaloridine (in 
Sterile Saline) 25 i.p. 8 weeksD
os
e-
re
sp
on
se
 s
tu
dy
 
8 experiment
 
 
Table 4: Group number, animals/group, treatment, doses, somministration route and animal age for 
dose range study with Cephaloridine (Phase II). 
 
 
 
3.3 Tissue collection 
At necropsy, each rat was euthanized with isofluorane and a sample of blood was 
collected from heart in eparinized tubes, centrifuged for 10 min at approximately 
2000 g and plasma was used for standard clinical chemistry analysis.  
Upon the removal of the kidneys, the wright kidney was cut transversally into 
three portion, a central and two peripheral. The central was placed in 10% neutral 
buffered formalin for histopathology. From one peripheral portion, 3mm3 pieces 
(cortical region) was sampled, fixed and stored in 4% formaldehyde/1% 
gluteraldehyde in phosphate buffer solution for possible future Electron 
Microscopy investigations. The last peripheral portion was frozen into cold N-
Hexane and stored at -80°C for possible future immunohistochemical analysis. 
The left kidney was collected and chopped into smaller pieces (~3-5 mm3) 
(cortical region), collected into 5 mL RNALater reagent and stored at -80C for 
gene expression measurement. 
All animals received complete post-mortem examination for gross abnormalities 
during collection of tissues for histopathologic evaluation and RNA exctraction. 
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3.4 Clinical Chemistry  
The traditional clinical chemistry parameters of nephrotoxicity, BUN and 
creatinine, were measured using an automated chinical chemistry analyzer 
(ADVIA 1650 Chemistry System, Siemens). 
The method for BUN quantification is based on Talke and Schubert enzymatic 
procedure (1965) for determination of urea using the coupled urease/glutamate 
dehydrogenase (GLDH) enzyme system. The assay has been optimized for 
analyzers that permit kinetic (fixed-time) measurements. 
After addion of a buffer/NADH and buffer/enzymes/substrate reagents to the 
sample, urea is hydrolyzed by urease to form CO2 and ammonia. The ammonia 
formed then reacts with α-ketoglutarate and NADH in the presence of GLDH to 
yield glutamate and NAD+. The decrease in absorbance due to consumption of 
NADH is measured kinetically (2 points-kinetic enzymatic UV method). 
Creatinine determination method in the plasma is based on Jaffe’ reaction as 
described by Popper and Mandel (1937). In alkaline solution, creatinine forms a 
yellow-orange complex with picrate. The color intensity is directly proportional to 
the creatinine concentration and can be measured photometrically (1 point-kinetic 
colourimetric method). 
 
3.5 Histology 
Kidney section for histology was fixed in 10% neutral buffered formalin.  
Within 48 hours of placement in formalin, kidney samples were dehydrated by 
passage through serial baths of graded alcohol and toluene. The dehydrated 
samples were embedded in paraffin, and 3 μm-thick sections were stained by 
hematoxylin and eosin (H&E) and Periodic Acid Schiffs (PAS).  
At microscopic examination, tubular cell degeneration, necrosis, regeneration 
were graded as minimal to marked according to the percentage of tubules 
involved (Minimal: 10-20%; Mild: 30-50 %; Moderate: 60-70 %, Marked: 80-
100%). 
The severity of tubular dilation with scattered cell degeneration/cast/debris was 
graded according to the extension of the damage (Minimal: cortex only; Mild: 
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cortex to outer medulla; Moderate: cortex to upper portion of inner medulla; 
Marked: cortex to deep portion of inner medulla (papilla)). 
 
 
3.6 Gene Expression  
Details for consumables for gene expression processing is reported in Table 5. 
 
Category Consumable Source 
RNALater™ Ambion (Europe) Ltd via CELBIO S.p.a., Milano, Italy 
TRIzol Reagent Invitrogen S.R.L., Milano, Italy 
RNeasy Mini kit Qiagen S.p.A., Milano, Italy 
6000 Nano Reagents & Supplies 
Kit  
Agilent Technologies S.p.a.,  
Milano, Italy 
RNA 
Isolation, 
quantity/ 
quality 
checks 
RiboGreen™ Assay Kit Invitrogen S.R.L., Milano, Italy 
DNase 1 RNase-free Ambion (Europe) Ltd via CELBIO S.p.a., Milano, Italy 
Superase-Inhibitor Ambion (Europe) Ltd via CELBIO S.p.a., Milano, Italy 
Nuclease-free water Invitrogen S.R.L., Milano, Italy 
96-well Optical Reaction Plate Applera Italia, Monza, Mi, Italy 
High Capacity cDNA Archive Kit Applera Italia, Monza, Mi, Italy 
RT Random Primers  Applera Italia, Monza, Mi, Italy  
DNase 
Treatment 
and cDNA 
Synthesis 
dNTP Mix (10 mM) Applera Italia, Monza, Mi, Italy  
Low Density Array Rat 
Endogenous Control Panel 
Applera Italia, Monza, Mi, Italy  
KIM-1, Cln, Rgn, Spp1 Gene 
Expression Assays 
Applera Italia, Monza, Mi, Italy 
Universal PCR Mix Applera Italia, Monza, Mi, Italy 
96-well Optical Reaction Plate Applera Italia, Monza, Mi, Italy 
TaqMan™ 
qRT-PCR 
Optical PCR Film Applera Italia, Monza, Mi, Italy 
 
Table 5. List of consumables used for gene expression processing. 
 
3.6.1 RNA isolation  
Rat kidney samples stored in RNALater at -80°C were weighed and eventually cut 
to obtain a piece of approximately 30 mg. RNA isolation and purification was 
performed using the RNeasy Mini kit (Qiagen).  
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Each sample was homogenised in 600 μL Buffer RLT using the Qiagen Tissue 
Lyser. An equal volume of 70% (v/v) ethanol was added to the homogenized 
lysate. The mixture was transferred to mini RNeasy column and centrifuged for 
15 s at 11,000 g. After discarding the flowthrough, 700 μL Buffer RW1 were 
added to the RNeasy colum and centrifuged for 15 s at 11,000 g to wash the 
column. The RNeasy column was then transferred into a new collection tube and 
500 μL Buffer RPE were added to the column and centrifuged for 15 s at 11,000 g 
to wash the column. This step was repeated twice. To elute RNA, 50 µL RNase-
free water were added to the column and centrifuged for 1 min at 11,000 g.  
 
 
3.6.2 RNA quantity check 
Total RNA was roughly quantified by UV spectrophotometer (Eppendorf) 
measuring the absorbance at 260 nm (A260). Both RNA and DNA absorb UV light 
making it possible to detect and quantify either at concentrations as low as 2.5 
ng/µl. The nitrogenous bases in nucleotides have an absorption maximum at about 
260 nm. Using a 1-cm light path, the extinction coefficient for nucleotides at this 
wavelength is 20. Based on this extinction coefficient, the absorbance at 260 nm 
in a 1-cm quartz cuvette of a 50µg/ml solution of double stranded DNA or a 
40µg/ml solution of single stranded RNA is equal to 1. For this reason, the RNA 
concentration in a sample can be calculated as follows: 
RNA concentration (µg/ml) = (A 260) x (dilution factor) x (40 µg RNA/ml)/(1 A260 
unit) 
Absorbace was also measured at 280nm so that A 260/280 for each sample could 
be calculated to give an indication of sample purity. In contrast to nucleic acids, 
proteins have a UV absorption maximum of 280 nm, due mostly to the tryptophan 
residues. The absorbance of a DNA sample at 280 nm gives an estimate of the 
protein contamination of the sample. The ratio of the absorbance at 260 nm/ 
absorbance at 280 nm could be calculated to give an indication of sample purity. 
It should be between 1.65 and 1.85. 
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3.6.3 DNAsing treatement 
To eliminate any possible genomic DNA contamination, samples were treated 
with DNase 1 enzyme (Ambion). To 20μg RNA were added 4U DNase, 20 U 
Superase and nuclease-free water to a final volume of 50 μl. Samples were 
incubated in a thermocycler for 10 minutes at 37°C, followed by 5 minutes at 
75°C.  
 
3.6.4 DNased RNA quality check 
DNased RNA quality was checked by the Bioanalyzer 2100 (Agilent 
Technologies), using a RNA 6000 Nano kit. The Bioanalyzer allows the 
evaluation of RNA status (degradation) by a micro-electrophoretic analisys on a 
chip. Since the majority of RNA (approximately 80%) in the samples is ribosomal 
and RNase activity digests RNA to give smaller fragments, this can be detected by 
electrophoresis. 
A gel-dye mix was prepared by adding 1 μL of dye concentrate into 65 μL of 
filtered gel and then centrifuged at 13,000g for 10 minutes. The gel-dye mix was 
loaded into a chip and 5 μL of a heat denatured ladder and 1 μL of heat denatured 
samples (approximately 200 ng) were pipetted into specific wells together with 5 
μL marker. For optimal performance of the total RNA (6000 Nano) assay, sample 
RNA concentration should be 5-500 ng/μL. The chip was vortexed for 1 min at 
2400 rpm and run on the Agilent 2100 Bioanalyser instrument.  
The Bioanalyzer provides a platform that uses a fluorescent assay involving 
electrophoretic separation to evaluate RNA samples qualitatively. The 
Bioanalyzer measures the amount of fluorescence as the RNA sample is pulsed 
through a microchannel over time. The software creates a graph called an 
electropherogram, which diagrams fluorescence over time. For each sample the 
software creates a gel image to accompany the graph. Smaller molecules are 
pulsed through the separation channel quicker than larger ones and will therefore 
appear on the left side of the electropherogram.  
The gel view of the electrophoresis should show two clear bands due to the 18S 
and 28S ribosomal RNAs (Fig.10). 
 43
 
 
 
 
 
 
 
 
 
 
 
 
Fig.10. Example of high quality RNA sample electropherogram and gel image (showing 3 peaks 
corresponding to marker, 18S and 28S ribosomal units, respectively).  
 
3.6.5 DNased RNA quantity check by RiboGreen™ assay 
DNased RNA was quantified using the RiboGreen™ RNA Quantitation Kit 
(Molecular Probes, Leiden) to have an exact value of RNA in each sample for 
cDNA synthesis.This is a fluorescent probe that binds nucleic acids specificly and 
gives a direct quantification of RNA by fluorescence detection.  
Aliquots of 1x TE buffer were distributed into appropriate wells on a 96-well 
plate. Ribosomal RNA was used to make a standard curve with final 
concentrations ranging from 0 to 200 ng/mL. Aliquots of diluted (from 1:2000 to 
1:64000) total RNA isolates were added into subsequent wells followed by the 
addition of the fluorescent RNA binding reagent (100 μL, using a 1 in 2000 
dilution of stock in 1x TE buffer) into wells whether containing samples or 
standards. The 96-well optical reaction plate was sealed with optical PCR film 
followed by centrifugation for 1 minute.  The fluorescence in each well was 
measured using the a plate fluorescence reader (SpectraMax Gemini XPS, 
Molecular Devices) with λ-480 nm excitation and λ-520 nm emission. The 
concentrations of the total RNA isolates were interpolated from the standard 
curve.  
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3.6.6 Reverse-Transcriptase PCR (cDNA sinthesys) 
Synthesis of the cDNA template was based on the ABI High Capacity cDNA 
Archive Kit. Reverse transcription was carried out in the presence (RT+) and 
absence (RT-) of the Superscript II reverse transcriptase enzyme. The RT- sample 
was prepared to allow the identification of eventual genomic DNA contamination. 
RT+ samples were created in duplicate (a and b) to evaluate variability caused by 
RT-PCR reaction. Nuclease-free water was added for the no template control 
samples (NTC) into the 96-well plate of the DNase treated samples.  
On the basis of RiboGreenTM measurements, 4 μg RNA were added to an 
appropriate volume of nuclease-free water to make the total volume equal to 70 
μL. Aliquots of the master mix [30 μL per well, 10X RT Buffer (10 μL), 10X RT 
Random Primers (10mμL), 100mM dNTP (4 μL), 50U/μL Multi-Scribe RT (5 
μL) and 20U/μL Superase-Inhibitor (1 μL)] were added to 70 μL RNA. 
The plate was sealed with adhesive PCR film, centrifuged for 1 minute at 4°C, 
incubated at room temperature for 10 min and heated to 37°C for 2 hours. 
Samples were stored at -20ºC until required. 
 
3.6.7 Endogenous control (housekeeping) gene selection by Low Density 
Array 
For meaningful gene expression measurement, an endogenous control or 
housekeeping gene, with constant expression level is essential to control for 
differences between samples. For this purpose the TaqMan Low Density Array 
Rat Endogenous Control Panel (Applied Biosystems, ABI) was used because it 
allows a rapid screening of many samples across many genes. It consists of the 
most commonly used housekeeping genes that are provided as a pre-formulated 
set of pre-designed probe and amplification primers (TaqMan gene expression 
assay). Different 16 rat housekeeping genes were screened (Table 6). 
Each TaqMan gene expression assay consists of a fluorogenic FAM™ dye-
labeled MGB (minor groove binder) probe and two amplification primers 
(forward and reverse) provided in a pre-formulated 20X mix; 1X final 
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concentrations are 250 nM for the probe and 900nM for each primer. Each assay 
has an amplification efficiency of 100% +/- 10%.  Each assay on the Low Density 
Array is spotted in triplicate into the 384 wells.  
For HKGs screening, 12 samples from the first experiment of the ageing study 
using HCBD and K2Cr2O7 (validation phase) were used (Table 2). Each cDNA 
(40 ng/μL) prepared from total RNA was diluted with RNase/DNase-free water 
and 2X TaqMan™ Universal PCR Master Mix to a final concentration of 1 ng 
cDNA/μL. Next, 100 μL of each single sample was loaded into one of the eight 
sample ports of the TaqMan Low Density Array Endogenous Control Panel. Two 
Low Density Arrays were used for this purpose, for running HCBD and K2Cr2O7 
samples, respectively. Each array loaded with the sample-specific PCR mix was 
sealed and cut off the fill reservoirs, centrifuged twice at 1000 rpm for 1 min to 
distribute the PCR mix into the wells, and placed into the ABI 7900 HT (Applied 
Biosystems) with 384-plate block (Fig.11). The instrument heated to 50°C for 2 
minutes, ramped to 95°C for 10 minutes followed by 40 cycles of 95°C for 0.15 
minutes and 60°C for 1 minute. 
 
 
Figure 11. A real-time PCR machine (ABI7900HT)  
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3.6.8 TaqManTM Real Time-PCR  
Specific TaqMan™ Gene Expression Assays were used to quantify KIM-1, Cln, 
Rgn and Spp1. These assays consist of a 20X mix of unlabeled PCR primers and 
TaqMan™ MGB probe (FAM™ dye-labeled). They are designed for the detection 
and quantitation of specific genetic sequences in RNA samples converted to 
cDNA. 
Besides target genes (KIM-1, Cln, Rgn and Spp1), also an endogenous control 
gene (18S ribosomal RNA) resulted from the TaqMan Low Density Array Rat 
Endogenous Control Panel screening, was evaluated as an active reference.  
For each gene of interest a mastermix was prepared. The mastermix contained 1 
μL gene specific 20X TaqMan™ Gene Expression Assays, 10 μL 2X TaqMan™ 
Universal PCR Master Mix and 4 μL RNase/DNase-free water. 15 μL of 
mastermix was then added into each well of a 96 well optical reaction plate which 
contained 5 μL of the relevant template: RT+ a, RT+ b, and RT- cDNA. Reactions 
used cDNA from the equivalent of 40 ng RNA. Each plate contained also 12 no 
template control (NTC) wells to monitor non-specific priming and mastermix 
contamination. To generate a standard deviation for the relative quantity value of 
a target, each plate contained three replicates of the target and endogenous 
control. The 96-well optical reaction plate was sealed with optical PCR film 
followed by centrifugation for 1 minute.  The plate was then placed into the 
ABI 7900HT instrument and heated to 50°C for 2 minutes, ramped to 95°C for 10 
minutes followed by 40 cycles of 95°C for 0.15 minutes and 60°C for 1 minute. 
 
3.6.9 Gene expression data evaluation 
The amplification plots were evaluated using the RQ Manager Software (ABI). 
This tool used for gene expression quantification supports real-time relative 
quantification of nucleic acids using the comparative Ct method.  
This method uses the following arithmetic formula to achieve results for relative 
quantification, expressed as relative amount of mRNA (RQ):  
2 -∆∆ Ct 
where:  
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∆∆Ct = the normalized signal level in a sample relative to the normalized signal 
level in the corresponding calibrator sample. The normalized signal levels refer to 
the signals generated by the amplification of the target sequence in the unknown 
and calibrator samples which is normalized to the signal generated by the 
amplification of the endogenous control.      
The purpose of the internal control gene is to normalize the PCR products for the 
amount of RNA added to the reverse-transcription reactions. 
As calibrator an untrated control was chosen for each experiment and it was 
analyzed on every assay plate with the other samples for both target and 
endogenous control genes. 
The ∆∆Ct method is validated by demonstrating that the efficiency of the target 
amplification (gene of interest) and the efficiency of the endogenous control 
amplification (HKG) are comparable or equal.  
 
3.6.10 Statistical analysis 
Data were analyzed for statistical difference (p < 0.05, p < 0.01) between control 
and treated groups, using Statistica version 6.0 software. ANOVAs followed by 
Dunnett’s t test were performed on sample means. 
All data from plasma clinical chemistry and kidney gene expression were 
expressed as means +/- standard deviation (SD) and analyzed using Dunnett’s t 
test. 
Reference intervals for each gene were calculated in control animals treated with 
corn oil (HCBD vehicle) or sterile saline (K2Cr2O7 or Cephaloridine vehicle) 
using the Statistica version 6.0 software.  
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Gene Symbol Gene Name Context Sequence Category
Actb actin, beta CCTTCCTTCCTGGGTATGGAATCCT Cytoskeletal protein
Arbp acidic ribosomal phosphoprotein P0 TTCCTTAAGATCATCCAACTTTTGG Nucleic acid binding
B2m beta-2 microglobulin GTGCTTGCCATTCAGAAAACTCCCC Defense/immunity protei
18S Eukaryotic 18S rRNA TGGAGGGCAAGTCTGGTGCCAGCAG Molecular function unclass
Gapdh glyceraldehyde-3-phosphate dehydrogenase AACCCATCACCATCTTCCAGGAGCG Oxidoreductase
Gusb glucuronidase, beta TTACTTCAAGACGCTGATCGCCCAC Hydrolase
Ppia peptidylprolyl isomerase A GGATTCATGTGCCAGGGTGGTGACT Isomerase
Ppib peptidylprolyl isomerase B CTACAGGAGAGAAAGGATTTGGCTA Isomerase
Hprt hypoxanthine guanine phosphoribosyl transferase CAGGGATTTGAATCATGTTTGTGTC Transferase
Tbp TATA box binding protein CCCACCAGCAGTTCAGTAGCTATGA Transcription factor
Hmbs hydroxymethylbilane synthase TCTGCAAACGGGAAAACCCTTGTGA Hydrolase
Ywhaz tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide CTGCAACGACGTACTGTCTCTTTTG Miscellaneous function
Pgk1 phosphoglycerate kinase 1 ACCTGCTGGCTGGATGGGCTTGGAC Kinase
Rplp2 ribosomal protein, large P2 TGTCATCGCTCAGGGTGTTGGCAAG Nucleic acid binding
Tfrc transferrin receptor GTTTTTGTGAGGATGAGGACTATCC Molecular function unclass
Ubc ubiquitin C TCTTGGGTTTGATGGGGAGGTGTCT Molecular function unclass
Table 6: TaqMan Low Density Array Rat Endogenous Control Panel details. 
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4 RESULTS 
4.1 Phase I  
4.1.1  Ageing study 
4.1.1.1 Gene expression 
Kidney sample of male rats treated with a single injection of 100 mg/kg HCBD 
and 25 mg/kg K2Cr2O7 at different ages (6-, 14-, 26-, 38- and 48-week-old) were 
collected at 48h after dosing and processed through gene expression quantification 
following the different steps listed in scheme 1, such as tissue homogenization, 
RNA isolation, quantity check (absorbance), DNase treatment, quality and 
quantity check and cDNA synthesis. 
An endogenous control (housekeeping) gene was selected using samples from the 
first experiment of ageing study. Ideally, the internal control gene for quantitative 
gene expression studies should not be influenced by the conditions of the 
experiment. To identify the best candidate gene to use as endogenous control for 
normalization, the expression profile of different  16 rat housekeeping genes 
(Table 6) was determined for fourteen animals, 6-week-old, treated with 100 
mg/kg HCBD and 25 mg/kg K2Cr2O7 and related controls (Table 2). Each Taqman 
assay was run in triplicate for each sample. The average Ct with standard deviation 
(SD) for each sample was calculated and showed in Fig 12 for HCBD and in Fig. 
12 for K2Cr2O7.  
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Fig.12. mRNA expression of 16 putative rat endogenous controls across 7 samples (1-3 controls; 
4-7 HCBD treated animals). Each bar represents one individual and measures the average Ct (n=3); 
error bars are SD. 
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Fig.13. mRNA expression of 16 putative rat endogenous controls across 7 samples (8-10 controls; 
11-14 K2Cr2O7 treated animals). Each bar represents one individual and measures the average Ct 
(n=3); error bars are SD. 
 
 
The average Ct was then used to determine the average Ct and SD of Ct for each 
gene across the different samples. This SD was used to identify the gene with the 
least variation amongst the 16 genes examined (Fig.14 and 15). 
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Fig.14. Variation of 16 rat endogenous controls across 7 samples (1-3 controls; 4-7 HCBD treated 
animals) as measured by SD of Ct. 
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Fig.15. Variation of 16 rat endogenous controls across 7 samples (8-10 controls; 11-14 K2Cr2O7 
treated animals) as measured by SD of Ct. 
 
 
From these data, the rat endogenous control genes with the lowest SD in 6-week-
old control and HCBD and K2Cr2O7 treated animals, and therefore, the lowest 
variation across samples, was 18S (0.26 for HCBD and 0.28 for K2Cr2O7 
experiment). Thus, 18S appears to be the best candidate to serve as endogenous 
control under both conditions.  
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After endogenous control gene selection, the 4 genes of interest were evaluated in 
animals at different ages (6-, 14-, 26-, 38- and 48-week-old) treated with HCBD 
100 mg/kg and K2Cr2O7 25 mg/kg and their expression was normalized to 18S 
gene transcript to obtain relative amount of mRNA (RQ) for each gene.  
 
Variability in the expression of KIM-1, Cln, Rgn and Spp1 within control 
animals, at different ages, treated with corn oil (HCBD vehicle) or sterile saline 
(K2Cr2O7 or Cephaloridine vehicle) was evaluated by the variance analysis 
(ANOVA) test. Results showed no significant differences in gene expression for 
each gene in the 2 vehicle groups (Fig. 16, 17, 18, 19, 20). Moreover, no 
significant difference was evidenced with ageing.  
 
 
 
         
 
 
 
 
 
 
 
 
 
       
 
 
 
 
 
 
 
 
 
Fig.16. KIM-1 (A), Cln (B), Spp1 (C) and Rgn (D) expression (LogRQ) in control rats (corn oil 
and sterile saline groups) at different ages. 
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To evaluate the biological significance in gene expression changes, reference 
intervals for each gene were calculated for all control animals treated both with 
corn oil and sterile saline, using the normal distribution and the non-parametrical 
percentile methods. Reference intervals were calculated so that contain 95% of the 
test population (controls gene expression values).  
On the basis of this analysis, the following thresholds were obtained: 2.8 for KIM-
1, 1.5 for Cln, 2.5 for Spp1, and 0.4 for Rgn. Gene expression responses were 
considered biologically significant for changes in the appropriate direction (up-
regulation for KIM-1, Cln and Spp1; down-regulation for Rgn) and magnitude 
from control in at least three out of four animals in the treated groups.  
 
The age-dependent effects of HCBD and K2Cr2O7 on the four putative gene 
expression markers of nephrotoxicity were assessed. The transcript levels of the 
four genes in kidney tissue were compared to age-matched controls. Statistical 
significance was determined based on analysis of the group means using an 
ANOVA with a Dunnett’s t test. 
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Expression results for all genes, as fold changes, obtained in the HCBD ageing 
study are reported in Fig. 17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.17. KIM-1, Cln, Spp1, and Rgn mRNA expression (fold change). Transcript levels are shown 
for individual animals treated with a single i.p. injection of 100 mg/kg HCBD (blue box, n = 4) 
within each age group of 6-, 14-, 26-, 38-, or 48-week-old rats relative to average level in controls 
(vehicle: corn oil, yellow circle, n = 4). Statistical significance in a Student’s t test comparison of 
age-matched treated and control values is indicated (*p < 0.05).  
 
KIM-1 mRNA levels were significantly increased in all treated groups, up to 660-
fold over control at 26 weeks of age. 
Clusterin expression increased in all treatment groups, although statistical 
significance was noted only in 6-, 14- and 48-week-old rats.  The range for 
HCBD-induced Cln gene expression changes was more than an order of 
magnitude lower compared to HCBD-induced KIM-1 expression changes. 
Spp1 was observed to have expression patterns similar to clusterin since it showed 
an increased expression in all groups of treatment, not statistically significant in 
the 26-week-old group only, due to the variability within this group.  
Treatment with HCBD induced down-regulation of Rgn transcript, statistically 
significant in all groups.  
*
*
*
*
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*
*
*
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*
*
*
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The observed effect of treatment on the level and significance of change in genes 
associated with nephrotoxicity suggested a difference in sensitivity with the age 
for KIM-1 only, that showed the following order: 26-week-old » 14-and 38-week-
old > 6-week-old > 48-week-old. 
For the other genes, any difference in sensitivity to HCBD-induced renal damage 
in the five age groups was assessed. For two genes, Cln and Spp1, the increase 
was not statistically significant at 26 weeks due to variability in the expression of 
these genes within this group (caused by animal no.31) that accounted for the lack 
of statistical differences compared to controls, although the mean fold changes at 
26 weeks were 17- and 15-fold over control, respectively. 
 
Expression results for all genes, as fold changes, obtained in the K2Cr2O7 (25 
mg/kg) ageing study are reported in Fig. 18. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.18. KIM-1, Cln, Spp1, and Rgn mRNA expression (fold change). Transcript levels are shown 
for individual animals treated with a single s.c. injection of 25 mg/kg K2Cr2O7 (blue box, n = 4) 
within each age group of 6-, 14-, 26-, 38-, or 48-week-old rats relative to average level in controls 
*
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(vehicle: corn oil, yellow circle, n = 4). Statistical significance in a Student’s t test comparison of 
age-matched treated and control values is indicated (*p < 0.05).  
 
Treatment caused statistically significant increased expression of KIM-1 in all the 
age groups. One animal in the 38-week-old group (an.53) showed a gene 
expression value similar to controls. The range of drug-induced changes in KIM-1 
gene expression was greater than HCBD, starting from 14-week-old group up to 
1800-fold at 26 weeks, even if at 6 weeks of age, treated animals showed an 
increase of 65-fold, lower than HCBD at the same age-point.  
 Cln expression was significally increased in all groups of treatment, up to 63-fold 
increase at 48 weeks of age. Also in this case, the K2Cr2O7-induced increased 
gene expression was greater than HCBD starting from 14 weeks of age. No 
difference with controls values were observed for one rat in the 38-week-old 
group. 
 
Spp1 mRNA levels were significantly increased starting from 14-week-old group, 
up to 88-fold over control at 38 weeks of age, even though for one animal in this 
group no difference with controls values were observed (an. 53). 
Treatment with K2Cr2O7 induced down-regulation of Rgn transcript, starting from 
14-week-old groups. The variability within the 38-week group accounted for the 
lack of statistical difference compared to controls.  
 
The observed effect of K2Cr2O7 treatment on the level and significance of change 
in genes associated with nephrotoxicity suggested a difference in sensitivity with 
the age for all the four genes. At 6 weeks of age, all changes induced by the 
treatment were not statistically significant or lower than those induced in the other 
age groups. Moreover, KIM-1 and Spp1 genes resulted to be more sensitive to 
drug-induced renal injury in 26- and 38-week-old groups, respectively.  
For the other genes, Cln and Rgn, any further difference in sensitivity to K2Cr2O7-
induced changes was assessed.  
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4.1.1.2 Histopathology 
Histopathology diagnosis revealed that HCBD induced epithelial 
necrosis/regeneration of tubules located in the outer stripe of the outer cortex and, 
to lesser extent medullary rays, accounting for the S3 segment of the proximal 
tubules (Fig. 19). These changes were observed in 19/20 rats and were mild (1/19 
rat), moderate (8/19 rats), or marked (10/19 rats), and not age-related in incidence 
and severity. In addition, increase in cytoplasmic hyaline droplets was observed in 
the S1 and S2 segments/pars convoluta of the proximal tubules in 4/4 rats at 14 
weeks of age. This observation was graded as mild (1/4 rat) to moderate (3/4 rat) 
and was not associated with features of cellular degeneration.  
A single treated rat (no.31), aged 26 weeks, did not show any abnormalities at 
microscopic examination. 
 
K2Cr2O7 induced histopathological changes in the cortical S1 and S2 segments of 
the proximal tubules in 19/20 treated rats (Fig. 20). These consisted in epithelial 
vacuolar degeneration/necrosis at 6 weeks of age, which was graded moderate in 
3/4 rats or marked in one of them. Starting from 14 weeks of age, marked 
epithelial necrosis of the same tubular segment was observed in all treated rats. In 
addition, distally to necrotic segments, tubules were dilated, with scattered 
apoptotic cells in their lining and tubular lumina were filled by brightly 
eosinophilic proteinaceous casts and/or cellular debris. Tubular 
dilation/casts/debris were graded minimal (1/15 rats), mild (5/15 rats), moderate 
(5/15 rats) or marked (4/15 rats), according to the extension of the damage. 
Neither tubular epithelium necrosis nor tubular dilation/casts/debris, recorded at 
14 weeks of age and over, was age-related in incidence and severity. 
A single treated rat (no.53), aged 38 weeks, did not show any abnormalities at 
microscopic examination. 
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Fig.19 (a-b): Histopathological changes induced by HCBD administration. Necrotic cells (TN) 
were characterized by hypereosinophilic cytoplasm with loss of nuclear details, detachment from 
the basement membrane and exfoliation into the lumen. Regenerating tubules (*), characterized by 
mitotic figures, flattened cells with basophilic cytoplasm and large vesicular nuclei were also 
present. (b) At 14 weeks of age, increase in round eosinophilic cytoplasmic inclusions (hyaline 
droplets/HD) were observed in the pars convoluta. H&E 20X. TN: tub. necrosis; *: tub. 
regeneration; HD: hyaline droplets.    
*
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b 
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Fig. 20 (a-b): Histopathological changes induced by Potassium dichromate administration. (a) At 6 
weeks of age, degenerating epithelial cells showed swollen cytoplasm with clear, irregular-sized 
vacuoles (TVD). Scattered necrotic/apoptotic cells were also present (arrows). (b) At 14 weeks of 
age, tubular epithelial cells showed tubular necrosis and were characterized by hypereosinophilic 
cytoplasm and loss of nuclear details (TN). In addition, distal segments showed dilated lumina, 
occasionally containing necrotic debris.  H&E 20X. TN: tub. necrosis; TVD: tub. vacuolar 
degeneration; arrows: scattered apoptotic/necrotic cells 
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N
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4.1.1.3 Clinical chemistry  
Treatment with 100 mg/kg HCBD caused increases in plasma urea and creatinine 
in all groups after 48h from injection (Fig. 21, 22). Whilst increases were 
statistically significant in all groups of animals for urea, for creatinine the 
significance was observed in 6-, 14- and 48-week-old groups of animals only. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21. Change in plasma urea levels following treatment with a single i.p. injection 100 mg/kg 
HCBD in 6-, -14, -26, -38 or -48-week-old rats. Statistical significance was determined using 
Dunnett’s t test (*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 22. Change in plasma creatinine levels following treatment with a single i.p. injection 100 
mg/kg HCBD in 6-, -14, -26, -38 or -48-week-old rats. Statistical significance was determined 
using Dunnett’s t test (*p < 0.05). 
 
Treatment with K2Cr2O7 25 mg/kg causes statistically significant increases in 
plasma urea and creatinine starting from 14-week-old group, higher than 
increasing caused by HCBD (Fig. 23, 24). 
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Fig. 23. Change in plasma urea levels following treatment with a single s.c. injection 25 mg/kg 
K2Cr2O7 in 6-, -14, -26, -38 or -48-week-old rats. Statistical significance was determined using 
Dunnett’s t test (*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 24. Change in plasma creatinine levels following treatment with a single s.c. injection 25 
mg/kg K2Cr2O7 in 6-, -14, -26, -38 or -48-week-old rats. Statistical significance was determined 
using Dunnett’s t test (*p < 0.05). 
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4.1.2 Dose-response studies 
4.1.2.1 Gene expression 
 
Expression results for all genes, as fold changes, obtained after treatment in 8-
week-old rats with a single i.p. injection of HCBD at doses of 25, 50, or 100 
mg/kg are reported in Fig. 25. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.25. KIM-1, Cln, Spp1, and Rgn mRNA expression (fold change). Transcript levels are shown 
for individual animals treated with a single i.p. injection of 25, 50, or 100 mg/kg HCBD (blue box, 
n = 4) relative to average level in controls (vehicle: corn oil, yellow circle, n = 4). Statistical 
significance in a Student’s t test comparison of age-matched treated and control values is indicated 
(*p < 0.05).  
 
Treatment with HCBD caused a significant increase in KIM-1 expression in all 
groups, up to approximately 700-fold increase of group means over control at 100 
mg/kg. 
Clusterin mRNA levels were significantly increased (13-fold over control) in the 
high dose group only. 
Spp1 was significantly increased from 5-fold in the 50 mg/kg group up to 10-fold 
in the 100 mg/kg group. 
*
*
*
*
*
*
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Rgn transcript levels were decreased by HCBD treatment, and statistical 
significance was noted in the low and high dose group. 
 
 
Expression results for all genes, as fold changes, obtained after treatment in 8-
week-old rats with a single s.c. injection of K2Cr2O7 at doses of 8, 12.5, or 25 
mg/kg are reported in Fig. 26. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 26. KIM-1, Cln, Spp1, and Rgn mRNA expression (fold change). Transcript levels are shown 
for individual animals treated with a single s.c. injection of 8, 12.5, or 25 mg/kg K2Cr2O7 (blue 
box, n = 4) relative to average level in controls (vehicle: corn oil, yellow circle, n = 4). Statistical 
significance in a Student’s t test comparison of age-matched treated and control values is indicated 
(*p < 0.05).  
 
 
Treatment of rats with K2Cr2O7 at induced increased expression of KIM-1 in all 
groups, even if statistically significant in the high dose group only (mean 
expression of 1600-fold over control). The variability within the other groups 
accounted for the lack of statistical difference compared to controls, although 
mean expression in the low and intermediate groups where 25-fold and 600-fold 
over control). Also in the dose-response studies, K2Cr2O7 induced higher 
expression in KIM-1 gene compared to HCBD. 
*
*
*
*
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As observed for HCBD treatment, K2Cr2O7 caused significant increased Cln levels 
(45-fold over control) in the high dose group only, higher than increasing caused 
by HCBD. 
K2Cr2O7–induced changes in Spp1 expression were similar to those observed with 
HCBD, but statistically significant at the high dose only and of greater magnitude 
(27-fold over control). 
Rgn transcript levels were statistically decreased by treatment in the high dose 
group. Mean expression for this group was 10-fold higher compared to HCBD-
induced Rgn expression changes in the same group. 
 
4.1.2.2 Histopathology 
Single i.p. injection of HCBD at doses of 100, 50 or 25 mg/kg induced dose-
related histopathological finding in rats aged 8 weeks. At 100 mg/kg, 4/4 rats 
were affected by marked tubular necrosis/regeneration of the S3 segment/pars 
recta of proximal tubules. In 3 of these rats, this observation was associated with 
increase in cytoplasmic hyaline droplets in the S1 and S2 segments and graded 
mild (1/3) or moderate in 2 of them. At 50 mg/kg, tubular necrosis/regeneration 
was still present in 4/4 rats but appeared less severe, being minimal (3/4 rats) or 
mild (1/4). At 25 mg/kg, tubules of the S3 segment/pars recta were unaffected in 
all rat, while cytoplasmic hyaline droplets were mildly increased in 3/4 rats. 
 
Single s.c. injection of K2Cr2O7 at doses of 25, 12.5 and 8 mg/kg induced dose-
related histopathological finding in rats aged 8 weeks. At 25 mg/kg, 4/4 rats 
showed marked tubular necrosis of the S1/S2 segments of the proximal tubules. In 
addition, tubular dilation with single cell degeneration and intratubular 
casts/cellular debris was recorded for all these rats and was minimal (3/4 rats) to 
mild (1/4 rat). At 12.5 mg/kg, tubular vacuolar degeneration/necrosis was minimal 
in 1/4  rat, affecting only single cells within tubular lining, or moderate 2/4 rats. In 
these two, regenerating cells (mitotic figures/basophilic cells with prominent 
nuclei/nucleoli) were detected, admixed to those undergoing 
degeneration/necrosis. At 8 mg/kg, regeneration (increased mitotic figures), 
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without clear evidences of tubular cell necrosis, were seen in 2/4 rats, affecting a 
minimal number of tubules. 
 
4.1.2.3 Clinical chemistry  
Treatment with different doses of HCBD in animals at 8 weeks of age caused 
statistical significant increase in plasma urea and creatinine levels in the high dose 
group (100 mg/kg) (Fig. 27, 28). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27. Change in plasma urea levels following treatment with a single i.p. injection  HCBD (25, 
50 or 100 mg/kg) in 8-week-old rats. Statistical significance was determined using Dunnett’s t test 
(*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28. Change in plasma creatinine levels following treatment with a single i.p. injection  HCBD 
(25, 50 or 100 mg/kg) in 8-week-old rats. Statistical significance was determined using Dunnett’s t 
test (*p < 0.05). 
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Treatment with different doses of K2Cr2O7 in 8-week-old animals showed 
statistical significant increase in plasma creatinine and urea levels in the high dose 
group (25 mg/kg) (Fig. 29, 30). While the increase in plasma levels of creatinine 
were similar to HCBD, for urea the increase K2Cr2O7-induced was lower than 
HCBD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30. Change in plasma urea levels following treatment with a single s.c. injection K2Cr2O7 (8, 
12.5 or 25 mg/kg) in 8-week-old rats. Statistical significance was determined using Dunnett’s t test 
(*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 31. Change in plasma creatinine levels following treatment with a single s.c. injection 
K2Cr2O7 (8, 12.5 or 25 mg/kg) in 8-week-old rats. Statistical significance was determined using 
Dunnett’s t test (*p < 0.05). 
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4.2 Phase II 
4.2.1 Dose-response Cephaloridine study 
4.2.1.1 Gene expression 
The dose-dependent effects of Cephaloridine (250, 500, or 1000 mg/kg) on the 
four putative gene expression markers of nephrotoxicity were assessed (Fig. 32). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32. KIM-1, Cln, Spp1, and Rgn mRNA expression (fold change). Transcript levels are shown 
for individual animals treated with a single i.p. injection of 250, 500, or 1000 mg/kg Cephaloridine 
(blue box, n = 4) relative to average level in controls (vehicle: corn oil, yellow circle, n = 4). 
Statistical significance in a Student’s t test comparison of age-matched treated and control values 
is indicated (*p < 0.05).  
 
 
KIM-1 mRNA levels were significantly increased starting from 500 mg/kg to high 
dose group, up to 540-fold over control. 
Cln expression was increased (5-fold over control) by Cephaloridine at 1000 
mg/kg.  
Spp1 was observed to have expression patterns induced by Cephaloridine similar 
to Cln, showing increased mRNA levels (7-fold over control) in the high dose 
group. 
**
*
*
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No statistically and biologically significant changes were observed for Rgn 
expression levels in all Cephaloridine treatment groups. 
 
4.2.1.2 Histopathology 
Single i.p. injection of Cephaloridine at doses of 1000, 500 or 250 mg/kg induced 
histopathological finding in 8-week-old rats at 1000  mg/kg (Fig. 33). These 
consisted in tubular necrosis of the S2 segments of the proximal tubules with 
relative sparing of the S1 portion. Tubular necrosis was seen in 3/4 rats and 
graded mild in one rat or marked in two. In one of the rats severely affected, the 
damage started extending to the S3 portion of the proximal tubules. 
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Fig 33: Histopathological changes induced by Cephaloridine administration, consisting in tubular 
necrosis the proximal tubules with relative sparing of those in close proximity to the renal 
corpuscles, likely to represent the S1 portion. Few regenerating tubules were also present. 
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4.2.1.3 Clinical chemistry  
Treatment of 8-week-old rats with a single i.p. injection of 250, 500 or 1000 
mg/kg Cephaloridine showed no significant changes in plasma urea and creatinine 
levels after 48h from treatment (Fig. 33, 34). 
 
 
 
 
 
 
 
 
 
 
Fig. 33. Change in plasma urea levels following treatment with a single i.p. injection 
Cephaloridine (250, 500 or 1000 mg/kg) in 8-week-old rats. Statistical significance was 
determined using Dunnett’s t test (*p < 0.05). 
 
 
 
 
 
 
 
 
 
 
Fig. 34. Change in plasma creatinine levels following treatment with a single i.p. injection 
Cephaloridine (250, 500 or 1000 mg/kg) in 8-week-old rats. Statistical significance was 
determined using Dunnett’s t test (*p < 0.05). 
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5 DISCUSSION 
The identification and evaluation of novel biomarkers of target organ toxicity has 
been one of the main applications of genomic-based technologies (Fielden and 
Zacharewski, 2001; Goodsaid, 2003; Huang et al., 2001 and Storck et al., 2002). 
A common approach in the literature has been to use cDNA or oligo microarrays 
for the classification of xenobiotics based on their gene expression profiles.  
One area in which this approach has been recently applied is drug-induced 
nephrotoxicity in rodents. Many of published literature employed cDNA arrays to 
assess known xenobiotic-induced nephrotoxicity in rats (Huang et al., 2001). 
Gene expression changes were observed in a multitude of distinct pathways. Some 
of these are involved in tissue damage,  remodelling and regeneration, disruption 
of calcium homeostasis, oxidative stress. Many of these reports detail cellular 
pathways that are modulated through the course of lesion development.  
Signature of genes designed to indicate nephrotoxicity obtained by microarray 
technology need to be validated with an independent gene expression detection 
technology such as quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR).  
On the basis of published works, four genes were selected for evaluation in a 
rodent model of nephrotoxicity. All the selected genes correlate with known 
functional changes in response to drug-induced kidney injury.  
KIM-1, which encodes a type I cell membrane glycoprotein, was cloned from 
post-ischemic rat kidneys. As with clusterin and OPN, expression of KIM-1 is 
thought to be associated with de-differentiated tubular epithelial cells, although a 
role in cellular regeneration has not been established. During this process, the 
ectodomain of KIM-1 is shed into the lumen and excreted in the urine. Because 
the upregulation of KIM-1 occurs rapidly and is detected in the urine, it has been 
proposed as an accessible biomarker of renal proximal tubular damage in humans 
(Han et al., 2002).  
Clusterin, also known as sulfated glycoprotein-2 (SGP-2), is a ubiquitously 
expressed glycoprotein whose expression in the kidney is upregulated during 
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development, in response to drug-induced cortical tubular injury, as well as in a 
variety of renal diseases and toxicities (Correa-Rotter et al., 1998; Darby et al., 
1995; Dvergsten et al., 1994; Laping et al., 1997; Rosenberg and Silkensen, 1995; 
Schwochau et al., 1998 and Silkensen et al., 1997). Urinary clusterin excretion is 
detectable before serum creatinine changes (Aulitzky et al., 1992 and Eti et al., 
1993). The exact role clusterin plays in renal injury is not well understood. 
Because clusterin is able to induce cell aggregation for several cell types in vitro, 
its induction and active secretion by stressed cells during injury or remodeling 
have been hypothesized (Silkensen et al., 1995). In this scenario, clusterin would 
act as a “bridge” to keep cells in close proximity to allow for specific cell–cell 
interactions and signalling to occur.  
Increased expression of Spp1 has also been demonstrated in numerous rodent 
models of renal injury, not just those involving proximal tubular necrosis. In rats 
treated with high doses of gentamicin, Spp1 mRNA was detected in regenerating 
proximal tubules, proliferating cortical distal tubules, and medullary tubules 
(Verstrepen et al., 2001 and Xie et al., 2001). Two divergent roles for Spp1 have 
been proposed during the development of acute renal failure. It may be involved 
in macrophage infiltration that occurs in response to glomerulnephritis (Wuthrich 
et al., 1998). It also protects cells from ischemic injury in gentamicin-treated rats 
by inhibiting apoptosis through decreased inducible nitric oxide synthase (iNOS) 
expression (Noiri et al., 1999). Unlike clusterin, increased urinary osteopontin 
excretion has not been observed in response to renal damage; however, it has been 
shown to decrease in the urine of patients with primary glomerulonephritis (Gang 
et al., 2001). Under normal conditions, Spp1 is secreted in the urine where it acts 
to prevent calcium oxalate crystal aggregation and stone formation (Min et al., 
1998).  
Regucalcin, is the Ca2+-binding protein, and it plays an important role in the 
regulation of kidney cell functions related to Ca2+. In particular, regucalcin has an 
important role in the reabsorption of Ca2+ in the kidney cortex. Presumably, 
regucalcin is responsible for ATP-dependent transcellular Ca2+ transport, and it 
participates in the promotion of Ca2+  reabsorption in the nephron tubulo of kidney 
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cortex. Kidney regucalcin may play a physiological role in the regulation of 
calcium metabolism in blood through reabsorption of urinary calcium.  
Cell damage induced by nephrotoxicants (i.e., cisplatin) can induce significant 
changes in Rgn due to disruption of Ca2+ homeostasis (Chao, 1996 and Kurota and 
Yamaguchi, 1995), 
In this work of thesis the four selected genes were evaluated in male rats after 
treatment with HCBD, K2Cr2O7, and Cephaloridine, three nephrotoxicants that 
primarily injure specific regions of the proximal tubule via different mechanisms 
of action. 
In the first part of the experimental phase (validation), transcript levels of KIM-1, 
Cln, Spp-1, and Rgn were quantified after treatment with a single dose of HCBD, 
K2Cr2O7 in rats at different ages. The aim of this experiment was to investigate  
changes in genes identified as markers of drug-induced renal damage in rodents.  
Expression changes correlated with the appearance of segment-specific renal 
lesion caused by the two compounds. In particular, HCBD (100 mg/kg) treatment 
induced epithelial necrosis/regeneration of the S3 segment/pars recta of proximal 
tubules, not age-related in incidence and severity. High levels of plasma creatinine 
and urea were detectable in all HCBD treatment groups, indicating functional 
disruption of kidney. All the selected genes showed significant changes in 
expression after treatment with HCBD in all groups. One rat did not show any 
abnormalities at microscopic examination and  clinical chemistry analysis 
although at gene expression evaluation significant increases were observed in the 
same animal for KIM-1 levels. 
 
Treatment with a single dose of K2Cr2O7 (25 mg/kg) induced histopathological 
changes in the cortical S1 and S2 segments of the proximal tubules in treated rats. 
Morphological changes at 6-weeks were indicative of an early damage of tubular 
cells (degeneration/necrosis), while starting from the 14-week-old groups of 
animals the damage appeared already established (necrosis). The different level of 
damage induced by K2Cr2O7 was captured by gene expression analysis. In fact, 
within the panels of genes evaluated, KIM-1 only showed a significant increase at 
6 weeks of age. No significant alterations in plasmatic creatinine and urea were 
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assessed in the 6-week-old group. One rat did not show any abnormalities at 
microscopic examination, clinical chemistry analysis and gene expression 
evaluation. 
In the second part of low-scale validation phase, three different doses of HCBD 
and K2Cr2O7, including the high dose used in the ageing study, were selected and 
somministered to 8-week-old rats to monitor the progression/severity of 
compound-induced damage and its effect on traditional and genomic markers.  
Treatment with 25, 50, or 100 mg/kg HCBD  and 8, 12.5, or 25 mg/kg K2Cr2O7  
in animals at 8 weeks of age resulted in the same histopathologic, clinical 
chemistry and gene expression modifications assessed in the previous ageing 
study for the high dose groups (100 and 25 mg/kg, respectively).  
At intermediate dose with both nephrotoxicants, the same morphologic findings 
related with specific compound toxicity (S3 segment tubular necrosis/regeneration 
for HCBD and S1-S2 segments degeneration/necrosis for K2Cr2O7) were still 
present but showed a lower degree of severity. Moreover, at 8 mg/kg degeneration 
necrosis affected single cell (rather than the entire epithelium) in one animal only 
while an increase of mitotic figures in a minimal number of tubules was seen in 2 
animals. This observation was likely to represent the reparative process to a 
previous insult. The low severity of microscopic observations was captured by 
gene expression response. In particular, KIM-1 and Spp1 genes showed 
statistically significant increased levels in animals treated with intermediate dose 
and KIM-1 mRNA transcript only was significantly increased at low dose of both 
nephrotoxicants.  
On the contrary, clinical chemistry markers did not show any changes in plasma 
concentrations at the intermediate and low doses of HCBD or K2Cr2O7. 
Treatment of 8-week-old rats with a single injection of different doses of 
Cephaloridine (250, 500, or 1000 mg/kg) induced morphological findings (S2 
segment tubular necrosis) in three animals from the high dose group only. No 
changes in creatinine and urea plasmatic levels were observed in all the treated 
groups.  
At gene expression, KIM-1, Cln and Spp1 showed increases at high dose, 
although the increase was statistically significant for KIM-1 only. This was due to 
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the high variability of the high dose group given by an outlier animal that did not 
show any change at microscopic examination, clinical chemistry analysis and 
gene expression evaluation. Moreover, KIM-1 mRNA levels were statistically 
significantly increased also at 500 mg/kg, where no modifications were seen at 
histopathology and clinical chemistry analysis. 
In summary, genes whose expressions have been previously correlated with drug-
induced renal injury in rodents were evaluated using segment-specifictoxic 
compounds for the proximal tubule. Microscopic damage in proximal tubules 
reflected the severity of the insult, with marked necrosis being observed at the 
high doses. Lower doses induced less severe necrosis and/or degeneration. 
Plasmatic levels of traditional clinical markers for renal damage, urea and 
creatinine, did not correlate well with the microscopic alterations observed. In 
fact,  changes were detected only at high doses, after a significant damage to 
nephrons has already occurred, thus resulting not very sensitive. Tubular damage 
and severity evidenced in these experiments were correlated with gene changes. 
Commensurate with the damage, epithelial necrosis was associated with a greater 
abundance of gene expression changes. Interestingly, even low severity 
microscopic observations were evidenced by gene expression quantification. Our 
analysis suggested at least equal sensitivity of gene expression quantification by 
qRT-PCR technology compared to traditional morphological endpoints. 
This study suggested also KIM-1 as specific marker of tubular injury, which could 
provide a more sensitive indication of damage compared with traditional clinical 
measurements. Moreover, since its increased expression was evidenced also for 
low dose of nephrotoxicants where no morphologic modifications were observed, 
KIM-1 is likely to represent a potential predictive biomarker of nephrotoxicity.  
In conclusion, this study confirmed that gene expression quantification may be 
used to detect renal tubular damage induced by nephrotoxicants. Genomic 
responses could represent more sensitive tool to monitor renal damage in 
comparison with traditional morphological and biochemical end points.  
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